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Summary 
One of the key selection criteria for potential probiotics is the ability to adhere and 
colonise the host gastrointestinal tract (GIT). Probiotics compete for receptor sites at 
the host intestinal surface, preventing the colonisation of pathogens, thereby 
protecting the host from infection. In addition, several important intestinal functions 
are mediated by the binding of probiotics to host tissue. However, the molecular 
mechanisms and genotypic characterization of adhesive elements have not received as 
much attention as other aspects of probiotic research. The present study aims to 
contribute to this area of research. 
The first part of the study focused on monitoring the expression of mucus 
adhesion genes mub, mapA, adhesion-like factor EF-Tu and bacteriocin gene plaA of 
Lactobacillus plantarum 423, as well as mub, surface layer protein (slp) and EF-Tu of 
Lactobacillus acidophilus ATCC 4356 when grown in the presence of mucin, bile, 
pancreatin and at low pH. Real time PCR was used. mub, mapA and EF-Tu of strain 
423 were up-regulated in the presence of mucus and expression increased under 
increasing concentrations of mucus. Expression of mapA was up-regulated under 
normal gut conditions (0.3%, w/v, bile; 0.3%, w/v, pancreatin; pH 6.5) and at higher 
levels of bile (1.0%, w/v) and pancreatin (1.0%, w/v). Expression of mub was down-
regulated in the presence of bile and pancreatin at pH 6.5, whilst the expression of EF-
Tu and plaA remained unchanged. At pH 4.0, the expression of mub and mapA 
remained unchanged, whilst EF-Tu and plaA were up-regulated. Expression of mapA 
was down-regulated in the presence of 0.1% (w/v) cysteine, suggesting that the gene 
is regulated by a mechanism of transcription attenuation that involves cysteine. In the 
case of L. acidophilus ATCC 4356, none of the genes were up-regulated under 
increasing concentrations of mucin, whilst only slp and EF-Tu were up-regulated 
under normal and stressful gut conditions in vitro. 
In the second part of the study, male Wistar rats were used to evaluate which 
section of the gastrointestinal tract are colonised by L. plantarum 423 and 
Enterococcus mundtii ST4SA and determine the effect of adhesion. Fluorescent in situ 
hybridization (FISH) incorporating strain specific oilgonucleotide probes indicated 
strong fluorescent signals for L. plantarum 423 along the intestinal lining of the ileum 
and the cecum. L. plantarum 423 did not colonise the colon as indicated by real time 
PCR. Fluorescent signals were recorded for E. mundtii ST4SA across the epithelial 
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barrier of cecum and colonic tissue, suggesting that translocation took place. Real time 
PCR revealed highest cell numbers of strain ST4SA in the cecum and the colon. 
Haemotoxylin eosin staining of rat tissue revealed no change in morphology or any 
toxic effects induced upon adhesion of the strains. 16S rDNA PCR and denaturing 
gradient gel electrophoresis (DGGE) revealed a decrease in enterobacterial species 
whilst the lactic acid bacterial content remained unchanged. Strains 423 and ST4SA 
agglutinated yeast cells in vitro, indicating the possible presence of mannose 
receptors. It is well known that these receptors play a crucial role in the elimination of 
type 1 fimbriated strains of E. coli. It is thus safe to speculate that mannose receptors 
may have played a role in diminishing the enterobacterial content in the gut. 
The third part of the study encompassed characterization of cell surface proteins of 
L. plantarum 423 and their role in adhesion to Caco-2 cell lines. The strain lacks the 
typical surface layer protein whilst a multifunctional “intracellular” protein, 
elongation factor Tu (EF-Tu) and glycolytic enzymes glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) and triosephosphate isomerase (TPI) were detected. 
Removal of surface proteins reduced adherence of strain 423 to Caco-2 cell lines by 
40%, suggesting that these proteins play a role in adhesion. The ability of strain 423 to 
competitively adhere, exclude and displace Clostridium sporogenes LMG 13570 and 
Enterococcus faecalis LMG 13566 from Caco-2 cell lines, was studied. Adhesion of 
C. sporogenes LMG 13570 and E. faecalis LMG 13566 was inhibited by 70% and 
90%, respectively. Strain 423 excluded C. sporogenes LMG 13570 from Caco-2 cells 
by 73% and displaced the pathogen by 80%. E. faecalis LMG 13566 was excluded by 
60% and displaced from Caco-2 cells by 90%. Despite removal of the surface 
proteins, L. plantarum 423 was still capable of competitively adhering to Caco-2 cells 
and reduced adherence of C. sporogenes LMG 13570 by 50% and E. faecalis LMG 
13566 by 70%. 
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Opsomming 
Een van die sleutelkriteria vir die seleksie van ‘n potensiële probiotikum is die 
vermoë van die selle om aan die gasheer se gastro-intestinale weg vas te heg  en te 
koloniseer. Probiotika kompenteer vir reseptorsetels op die oppervlak van die gasheer 
se ingewande en verhinder sodoende die kolonisering van patogene en 
daaropvolgende infeksies. Aanvullend tot bogenoemde word verskeie belangrike 
intestinale funksies tydens vashegting van die probiotiese selle aan  die gasheer 
gestimuleer. Ten spyte hiervan geniet die molekulêre meganismes en genotipiese 
karakterisering van adhesie-elemente relatief min aandag in vergelyking met baie 
ander aspekte van navorsing op probiotika. 
Die eerste gedeelte van die studie fokus op die uitdrukking van die gene mub, 
mapA en die adhesie-tipe faktor EF-Tu wat vir hegting aan mukus kodeer, asook die 
bakteriosien-geen plaA van Lactobacillus plantarum 423. Die uitdrukking van mub, 
die slp-geen wat kodeer vir produksie van seloppervlak proteïene, en EF-Tu van 
Lactobacillus acidophilus ATCC 4356 is ook bestudeer. Laasgenoemde studies is 
gedoen tydens groei in die teenwoordigheid van mukus, galsoute, pankreatien en 
verlaagde pH. Intydse (“Real time”) polimerase kettingreaksie (PKR) is gebruik. mub, 
mapA en EF-Tu van stam 423 se regulering is opwaarts aangepas in die 
teenwoordigheid van mukus, met die uitdrukking proporsioneel eweredig tot die 
verhoging in mukus vlakke. Die uitdrukking van mapA het onder normale toestande 
(0.3%, m/v, gal; 0.3%, m/v, pankreatien; pH 6.5) en in die teenwoordigheid van hoër 
vlakke galsoute (1.0%, m/v) en pankreatien (1.0%, m/v) toegeneem. Die uitdrukking 
van mub het afgeneem in die teenwoordigheid van galsoute en pankreatien by pH 6.5, 
terwyl die uitdrukking van EF-Tu and plaA onveranderd gebly het. In ’n omgewing 
van pH 4.0 het die uitdrukking van mub en mapA onveranderd gebly, terwyl die 
uitdrukking van EF-Tu en plaA gestimuleer is. Uitdrukking van mapA is onderdruk in 
die teenwoordiging van 0.1% (w/v) sisteïen, wat daarop dui dat die geen deur ‘n 
meganisme van transkripsie-attenuasie in die teenwoordigheid van sisteïen gereguleer 
word. In die geval L. acidophilus ATCC 4356 is geenuitdrukking nie in die 
teenwoordigheid van hoë mukusvlakke gestimuleer nie. Die uitdrukking van slp en 
EF-Tu is onder normale en stresvolle toestande in die ingewande gestimuleer. 
In die tweede afdeling van die studie is manlike Wistar rotte gebruik om te bepaal 
presies watter deel van die gastro-intestinale weg deur L. plantarum 423 en 
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Enterococcus mundtii ST4SA gekoloniseer word. In situ fluorisensie hibridisasie 
(FISH) met stam-spesifieke oligonukleotiedpeilers het aangetoon dat L. plantarum 
423 op die mukosa van die ileum en die sekum vestig. L. plantarum 423 het nie die 
dikderm gekoloniseer soos deur intydse PKR voorspel is nie. Fluoriserende selle van 
E. mundtii ST4SA is op epiteelselle van die sekum en kolon waargeneem en dui dus 
op translokasie van die selle. Intydse PKR het hoë selgetalle van stam ST4SA in die 
sekum en die kolon aangetoon. Haemotoksilien-eosin kleuring van die weefsel het 
geen verandering in morfologie of enige toksiese defekte getoon as gevolg van 
adhesie nie. 16S rDNA PKR en denaturende gradient-gel elektroforese (DGGE) het 
op ’n verlaging in aantal ingewanndsbakterieë gedui, terwyl die selgetalle vir 
melksuurbakterieë onveranderd gebly het. Binding van stamme 423 en ST4SA aan 
gisselle dui op die moontlike voorkoms van mannose reseptore. Dit is algemeen 
bekend dat mannose reseptore ‘n essensiele rol speel in die eliminasie van E. coli 
stamme met tipe-1 fimbrae. Dit is dus veilig om te spekuleer dat reseptore vir 
mannose ‘n belangrike rol speel in die verwydering van ingewandsbakterieë. 
Die derde gedeelte van die studie het die karakterisering van sel-oppervlak 
proteïene van L. plantarum 423, en hul rol in die vashegting aan Caco-2 selle, behels. 
Stam 423 ontbreek die tipiese oppervlak-proteïen, terwyl ‘n multi-funksionele 
intrasellulêre proteïen, verlengingsfaktor TU (EF-Tu) en die glikolietiese ensieme 
gliseraldehied 3-fosfaat dehidrogenase (GAPDH) en triofosfaat isomerase (TPI) 
opgespoor is. Verwydering van oppervlak-proteïene het die vashegting van stam 423 
aan Caco-2 sellyne met 40% verminder en dui daarop dat hierdie proteïene ‘n rol speel 
in adhesie. Die vermoe van stam 423 om kompeterend vas te heg en Clostridium 
sporogenes LMG 13570 en Enterococcus faecalis LMG 13566 van Caco-2 selle te 
verplaas, is bestudeer. Vashegting van C. sporogenes LMG 13570 en E. faecalis LMG 
13566 is onderskeidelik met 70% en 90% ge-inhibeer. Stam 423 het suksesvol met C. 
sporogenes LMG 13570 vir vashegting aan Caco-2 selle gekompeteer en het  73% van 
die selle verplaas en  80% van die patogeen verplaas. E. faecalis LMG 13566 is met 
60% uitgeskakel en is teen 90% verplaas. Ten spyte van die verwydering van 
oppervlak-proteine was L. plantarum 423 nogsteeds daartoe in staat om kompeterend 
aan Caco-2 selle vas te heg en die kolonisering van C. sporogenes LMG 13570 met 
50% en E. faecalis LMG 13566 met 70% te verminder. 
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Chapter 1 
 
 
 
Introduction 
 
Motivation for the study 
Probiotic properties of lactic acid bacteria have initiated various discussions, 
resulting in the increased growth of research in this field, one of which has attempted 
to understand the role of adhesion of these organisms.  
The strong adhesive ability of some Lactobacillus spp. to host intestinal tissue has 
been demonstrated (9, 11). However, controversy on the importance of this property 
for probiotic potential arose, since the ability of a pathogen to adhere to host tissue is 
considered a virulence factor (2). It was later shown that unlike pathogens, the 
adhesive ability of lactobacilli is not a universal property and that adhesion does not 
elicit infection (1, 7). It was thus concluded that the high adhesive properties of 
lactobacilli are not a virulence trait and do not pose as a potential risk factor (7). 
Adhesion of probiotics to intestinal mucosa is now considered one of the main 
selection criteria (10, 12). 
The ability of probiotics to inhibit or eliminate diarrhoea is possibly the most 
validated health benefit reported (3) and is discussed in Chapter 2. This effect depends 
on the adhesion of probiotic bacteria to host intestinal tissue and subsequent 
colonization of the gastrointestinal tract. Lactic acid bacteria and pathogens compete 
for receptor sites at the intestinal surface. Competition for these receptors will 
diminish the opportunity for pathogenic colonization and thus protect the host from 
infection (5). The molecular mechanism surrounding host-microbial interactions was 
demonstrated by the colonization of Bacteroides thetaiotaomicron (major commensal 
of human and mouse intestinal microflora) to germ-free mice (6). Several important 
intestinal functions, including mucosal barrier reinforcement, xenobiotic metabolism, 
nutrient absorption, detoxication and postnatal intestinal maturation facilitated by 
mere adhesion of the strain, was reported (6). Adhesion of probiotics also play a 
substantial role in stimulating the immune system by enhancing the natural immune 
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response (15). In addition to the inhibition of pathogenic colonization and immune 
stimulation, the adhesion of probiotics is also imperative to prolong their persistence 
and beneficial role in the gastrointestinal tract.  
Protein and carbohydrate molecules play a substantial role in mediating the 
adhesion of lactobacilli to host surfaces (13). However, molecular characterization of 
adhesive elements have not received much attention as only a few of these molecules 
have been characterized. More than 300 peer-reviewed articles on probiotics are 
published annually, indicating the significant interest in this field (8). However, very 
limited number of these reviews focus on the mechanisms of probiotic action, 
particularly with respect to the mechanisms of adhesion (8). Most of the research 
conducted on adhesion focuses primarily on in vitro adhesion of the potential 
probiotic to adhesion models such as cell lines or mucus preparations. These studies 
provide significant insight on the adhesive ability of the probiotic. However, it may 
not provide adequate information on the mechanisms of adhesion, particularly at the 
molecular level. Most probiotics are selected based on their superior phenotypic 
ability (tolerance to bile, acid, antimicrobial activity, etc.) and not on their unique 
ability to confer a defined health benefit. Similar probiotics may have different 
mechanisms of action against different pathogens. Understanding the molecular 
mechanisms of probiotic action, particularly the mechanisms of adhesion, will provide 
the scientific rationale for selection of the best species or strains that target a specific 
health problem.  
In light of the abovementioned, this research focused on characterization of the 
adhesive properties of Lactobacillus plantarum, Enterococcus mundtii and 
Lactobacillus acidophilus at the molecular level. Most of the research in the present 
investigation was conducted on L. plantarum, as the organism displays strong 
adhesive ability and excellent probiotic potential. Examination of in vivo gene 
expression of certain lactobacilli indicated that expression of 3 Lactobacillus reuteri 
and 72 L. plantarum genes were induced in the murine gastrointestinal tract (4, 14). 
Most of the gut-inducible L. plantarum genes were involved in nutrient assimilation, 
stress response and modification of cell surface protein composition. Such responses 
indicate that the organism is metabolically active and adaptive to the gastrointestinal 
tract (4, 14). 
Efficient colonization of a probiotic can only be facilitated by overcoming 
digestive stress conditions such as tolerance to bile, pancreatic juice and low pH. In 
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vitro expression of adhesion genes under digestive stress conditions have not been 
previously studied. The first part of study focused on the adhesion gene expression of 
Lactobacillus plantarum 423 and Lactobacillus acidophilus 4356 when cultured in the 
presence of varying concentrations of mucus, bile, pancreatin and pH. The role of the 
surface layer protein (Slp) in adhesion was studied by investigating the regulation of 
the gene in the presence of mucus. 
In vitro analysis provides valuable preliminary information on the properties of a 
potential probiotic. However, in vitro analysis is not a complete representation of the 
actual results, making in vivo analysis essential. The second part of the study included 
the use of rat models to determine which section of the gastrointestinal tract was 
colonised by L. plantarum 423 and Enterococcus mundtii ST4SA. L. acidophilus was 
not considered in this part of the study as it was only incorporated in the first section 
to determine the role of Slp in adhesion. Molecular techniques such as fluorescent in 
situ hybridization (FISH), 16S rDNA PCR and denaturing gradient gel electrophoresis 
(DGGE) were used to evaluate adhesion of strains 423 and ST4SA to enterocytes as 
well as the effect on the natural microflora of rats.  
In the last part of the study, the surface proteins of L. plantarum 423 were 
characterized, with interest in distinguishing the presence of a surface layer protein. 
The role of the surface proteins in adhesion of the strain to Caco-2 cell lines was also 
examined. The ability of the strain to competitively exclude Clostridium sporogenes 
LMG 13570 and Enterococcus faecalis 13566 from Caco-2 cell lines, was also 
examined.  
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Chapter 2 
 
 
 
Literature review 
 
2.1 A brief history on probiotics 
The therapeutic use of lactic acid bacteria was applied in the early centuries to 
improve the storage quality, nutritive value and flavour of perishable foods, without 
the existence of these microorganisms being recognised. Lactic acid fermentations 
served as a valuable food source for people of different cultures and played a pivotal 
role in prolonging the life of early descendents (206). Russian scientist Elie 
Metchnikoff first proposed the curative benefits of lactic acid bacteria at the beginning 
of the 20th century (159). This facilitated a profusion of experiments leading to their 
prevalent use as dairy starter cultures, incorporation in a number of functional foods to 
pharmaceutical applications with promoted health benefits (151, 206).  
Lactic acid bacteria are Gram-positive, catalase negative and asporogenous. 
Fermentable sugars are converted to lactic acid via one of two metabolic pathways, 
i.e. the glycolytic pathway and pentose-phosphate pathway (8). The first pure culture 
of a lactic acid-producing bacterium, classified as “Bacterium lactis” was isolated 
from rancid milk in 1873 by J. Lister (8). This led to a progression in the classification 
of lactic acid bacteria isolated from various sources, including the gastrointestinal tract 
(GIT) of humans and animals. Four genera that predominantly compose this group 
include Lactobacillus, Leuconostoc, Pediococcus, Streptococcus and Enterococcus, 
with lactobacilli and enterococci being the major commensals of the human GIT (8, 
250). 
The “Bulgarian bacillus” isolated from Bulgarian yoghurt by a Swiss scientist, was 
the first strain to be incorporated in human trials. However, the strain was incapable of 
surviving gastric transit (159, 191). This necessitated the need for isolates to be of 
human origin as it was perceived that these bacteria would overcome digestive stress 
conditions and maintain a competitive advantage in the gut (159). Subsequently, the 
selection of human derived isolates as compared to those of fermented origin, gained 
attention. Bifidobacteria were first isolated from the faeces of breast fed infants (156). 
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Bifidobacteria are obligate anaerobes and constitute a major part of the intestinal 
microflora (250). They are phylogenetically distinct from lactic acid bacteria as they 
exclusively degrade hexoses via the fructose-6-phosphate pathway (8). They play a 
fundamental role in colonisation of the human gut and implement favourable health 
effects (181). As a result, bifidobacteria as probiotics have gained considerable 
interest and remain one of the major starter cultures in the dairy industry (96). 
The first report of a Lactobacillus sp. included Lactobacillus acidophilus, isolated 
from infant faeces by Moro in 1900 (75). Various “acidophilus” strains have 
subsequently been isolated from the intestinal tract of humans and animals. However, 
molecular taxonomic methods indicated that these “acidophilus” strains were 
composed of at least six different species, namely L. acidophilus, L. crispatus, L. 
gallinarum, L. amylovorus, L. johnsonii and L. gasseri (29, 59, 106, 120). Molecular 
analytical methods indicated that L. casei, L. paracasei and L. rhamnosus are the 
prevalent Lactobacillus spp. in the human gut (160, 226). Lactobacillus casei was 
used as a probiotic for the first time in 1935 when strain Shirota was included in a 
yoghurt preparation called Yakult. The strain is resistant to gastric and bile acid and is 
documented to generate health benefits when ingested (145).  
One of the most extensively researched probiotic microorganisms is L. rhamnosus 
GG (LGG) (76, 216). The strain is of human origin and was identified from a 
selection of lactobacilli as possessing the best probiotic characteristics (70). Strain GG 
is capable of tolerating bile salts, pancreatic enzymes and gastric acid. It produces 
antimicrobial compounds and adheres to cells of the small intestine. The strain also 
survives passage through the gastrointestinal tract where it colonises and persists for 
days. Consequently, LGG was the first probiotic strain reported to colonise the human 
gastrointestinal tract (73).  
 
2.2 Mechanisms of probiotic action 
The mode of action by which a probiotic eradicates a pathogen can be summarised 
as suppression of viable cell numbers, altering the metabolism of pathogens and 
stimulation of the host immune system (61, 139). Suppression of viable cells may be 
facilitated by the production of antimicrobial compounds such as bacteriocins, organic 
acids and hydrogen peroxide (113, 195). The antagonistic activity of these compounds 
against Gram-positive and Gram-negative bacteria have been demonstrated in vitro. 
Bacteriocins play a significant role in the food industry where they prevent spoilage 
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by harmful microorganisms thereby improving the quality of food. However, not 
much is known about their activity in vivo (141, 239).  
Competition for nutrients also reduces pathogenic cell numbers as probiotics may 
utilise nutrients that may otherwise have been consumed by pathogens (61). Evidence 
for this occurring in vivo is also lacking. The effect of probiotics on microbial 
metabolism in the gut was demonstrated by the consumption of L. acidophilus. 
Suppression in the activity of selected enzymes such as β-glucuronidase, 
nitroreductase and azoreductase was observed (71). Further mechanisms for the 
alteration of microbial metabolism remain to be elucidated.  
The immune system is basically composed of acquired immunity (B lymphocytes 
and sensitised T lymphocytes) as part of the specific immune response and innate 
immunity that consists mainly of macrophages and natural killer (NK) cells as part of 
the non-specific immune response (172). L. casei Shirota enhanced proliferation of 
phagocytes such as macrophages and neutrophils in the bone marrow and spleen of 
mice (256). Direct activation of macrophages by strain Shirota augmented the 
bactericidal effect of macrophages on pathogenic bacteria such as Pseudomonas 
aeruginosa (152). Secretory IgA is a defence molecule produced as part of the 
acquired immune system in the intestine. The molecule plays a key role in maintaining 
a barrier against infection caused by pathogenic bacteria and viruses (51). Lactating 
mice treated with Bifidobacterium lactis Bb-12 showed significantly higher levels of 
total fecal IgA as compared to the controls (60). In addition, anti β-lactoglobulin IgA 
was higher in the faeces and in the milk (60). The acquired immunity (B lymphocytes) 
promoting effects of probiotics were also demonstrated by strain Shirota in a rabbit 
model. The probiotic not only prevented proliferation of enterohemorrhagic E. coli 
O157:H7, but also increased the intestinal antibody titre against O157:H7 and Shiga 
toxin produced by the pathogen (173). 
Competitive adherence to bacterial adhesion sites on epithelial surfaces is another 
important mechanism of action by probiotics (2, 34). Competition for these sites will 
not only diminish the opportunity for pathogens to proliferate, but more importantly 
protect the host from infection (190). The mucus layer plays a pivotal role in 
maintaining a protective lining over intestinal tissue, thereby preventing intestinal 
permeability (51). Pathogens produce mucinase which degrades the mucosal layer and 
compromise intestinal epithelial integrity, leading to infection (83). The ability to 
degrade mucus is thus considered a valuable indicator of pathogenicity and local 
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toxicity of lumen bacteria (51). Probiotic bacteria have exhibited the ability to bind to 
intestinal mucus. For example, 45% of Lactobacillus rhamnosus strains and 30% of 
Bifidobacterium lactis strains adhered to stool mucus after oral administration to 
humans (112). Lactobacilli adhere and propagate on the mucosal layer, as shown for 
the small intestine of pigs (194). The lack of mucinase enzymes in probiotic bacteria 
and the inability of certain strains to degrade mucus have promoted their safe use (99). 
This property has been demonstrated for probiotic strains L. casei GG, L. acidophilus, 
B. bifidum (200), L. rhamnosus and B. lactis (257). In addition, probiotics have 
demonstrated the remarkable ability to stimulate mucin production as another 
effective mechanism to prevent pathogenic colonisation (134). Probiotic strains L. 
plantarum 299v and L. rhamnosus GG demonstrated up-regulation of muc2 and muc3 
genes in human colonic HT-29 cells (134). Alternate mechanisms were proposed for 
the probiotic yeast, Saccharomyces boulardii. The yeast produces a protease capable 
of degrading the toxin A receptor for Clostridium difficile in animals, thus preventing 
adherence of the pathogen (187). A combination of all the processes by which 
probiotics hinder the colonisation of pathogens is referred to as colonisation resistance 
(195). Consequently, some probiotic strains have been selected purely based on their 
strong adhesive ability (195).  
 
2.3 Selection criteria for potential probiotics  
Health promoting effects of probiotics may either be acquired through 
incorporation in food components (functional foods) or as non-food preparations. In 
either situation the safety of the probiotic is of ultimate concern to the consumer. For 
this reason, Lactobacillus spp. and Bifidobacterium spp. have become popular choices 
due to their long history of safe use in the fermentation industry and being natural 
inhabitants of the gastrointestinal tract. These properties have conferred them with 
generally regarded as safe (GRAS) status (5, 94). This forms the basis for one of the 
first selection criteria for a potential probiotic. The safety assessment of each potential 
probiotic strain is imperative. Extrapolation of data from closely related strains is 
unacceptable (47). The strain should be well characterized and safety should be 
thoroughly evaluated in vitro, followed by in vivo studies. The efficacy of the 
probiotic should be evaluated by at least one human trial which should be double blind 
and placebo controlled (47, 84).  
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The efficiency of a probiotic depends on its viability and subsequent survival in 
the gastrointestinal tract. Strains of human origin are preferred over fermented origin 
as human isolates may possess a selective advantage in overcoming gastrointestinal 
conditions (47, 159). A potential probiotic will have to overcome harsh conditions in 
the GIT, such as survival at low pH, tolerance to bile acids and pancreatic juice, and 
efficiently colonise enterocytes. Secretion of more than two litres of gastric acid by 
the stomach daily constitutes a defense mechanism against most ingested 
microorganisms (41). The pH of gastric juice can reach values as low as 1.5 (41). 
Hence, survival of gastric transit by a probiotic is dependent on tolerance to low pH 
during a transit time of 1 to 4h (6).  
Organisms that survive gastric transit proceed to the small intestine where they 
encounter further stress associated with bile acids and pancreatic juice. Bile acids are 
synthesized from cholesterol in the liver and are secreted into the duodenum in a 
conjugated form (91). Conjugated bile acids then undergo various chemical 
modifications in the colon almost solely by microorganisms (89). Conjugated and 
deconjugated forms of bile acids are inhibitory to both Gram-positive and Gram-
negative bacteria. However, the deconjugated form is more inhibitory to Gram-
positive bacteria (52, 127). It is thus imperative for potential probiotic strains to be 
tested for their ability to tolerate bile acids. A comparative study on the ability of 
Lactobacillus and Bifidobacterium strains to endure various concentrations of bovine, 
porcine and human bile was conducted (240). Although the tested strains exhibited 
resistance to bovine bile, porcine bile proved more inhibitory to both groups. 
However, despite the resistance patterns to bovine and porcine bile, all strains grew 
under relevant physiological concentrations of human bile (240). The bile salt 
hydrolase gene (bsh) present in intestinal lactobacilli such as L. acidophilus, L. casei 
and L. plantarum codes for a bile salt hydrolase that hydrolyses bile acids to more 
soluble deconjugated bile salts (67). This may be one of the mechanisms by which 
intestinal lactobacilli counteract toxic concentrations of bile acids. 
Adhesion of a probiotic to enterocytes is important for colonisation and 
prolonging the beneficial role in the host. Of all available probiotics, L. rhamnosus 
GG has the longest retention time in the GIT (47, 72). The importance of this trait was 
demonstrated by the ability of L. rhamnosus GG to shorten the duration of rotavirus 
associated diarrhoea in infants (100). In a separate experiment, L. bulgaricus which 
does not adhere and colonise the GIT had no effect on alleviating rotavirus diarrhoea 
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(203). Intestinal mucus and human cell lines HT-29 and Caco-2 serve as valuable 
tools for assessing the adhesive properties of potential probiotic strains. The use of 
mucus and cell lines have been used to elucidate mechanisms of enteropathogen 
adhesion (15, 33) and assess lactic acid bacteria (LAB) on their adhesive properties 
(81, 177, 246).  
In addition to the medico-scientific (in vitro and in vivo assessment of the efficacy 
in terms of human health) selection for probiotic bacteria, a few technological criteria 
need to be met if the probiotic is to be commercialised (32). Probiotics are available in 
either frozen concentrated or freeze-dried forms, depending on the application. 
Freeze-dried preparations should be conducted with cryoprotection to ensure that the 
probiotic retains its viability during storage (maintain high shelf-life). If the organism 
is incorporated into functional foods, it should be capable of proliferating to high cell 
densities in inexpensive media under robust conditions. In either situation the 
probiotic should maintain its viability during storage and use (32).  
 
2.4 Beneficial role of probiotics in health 
The availability of antibiotics in the 1950’s facilitated their prevalent use as 
growth stimulants for animals and therapeutic agents (61). Growing concern over the 
years on the emergence of multi-drug resistant pathogens and associated side effects 
of antibiotic use has led to consumers and manufacturers seeking alternate measures. 
Probiotics pose an attractive alternative to overcome these problems. The mechanisms 
by which probiotics function, particularly in eliminating pathogens are diverse. 
Chances for the emergence of pathogens resistant to probiotics are thus minimal (51). 
In addition, the need for re-establishing the normal gut microflora after antibiotic 
therapy is eliminated (61, 195). The use of probiotic therapy may also prove a cheaper 
option compared to antibiotics (61). Probiotics have been documented to benefit the 
host in a number of ways and new health benefits are reported incessantly.  
Intestinal infections caused by pathogenic microorganisms such as Escherichia 
coli, Vibrio cholerae, Shigella spp., Campylobacter spp., Clostridium difficile and 
rotavirus are the main causes of death in developing countries (172). Even in 
developed countries such as the United States, 21-37 million cases of diarrhoea occur 
annually in a population of 16.5 million children (69). The overuse of antibiotics has 
resulted in an increase of nosocomial infections caused by multi-drug resistant 
pathogens. The adverse side effects of antibiotic therapy enhances the need for 
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probiotics. Consequently, the most prevalent use of probiotics has involved the 
treatment of intestinal infections in humans and animals (61). Rotaviral diarrhoea, 
characterized by vomiting and watery stool, is predominant in children aged between 
6 to 24 months. Treatment includes fluid replacement to counteract dehydration and 
nutritional deficiency. The effect of different probiotics for treatment of rotaviral 
diarrhoea was investigated in various double-blind placebo-controlled trials (100, 
222). L. rhamnosus GG significantly reduced the duration of diarrhoea in infants aged 
1-3 months compared to the placebo group. Similar results were obtained when L. 
reuteri SD 2222 was consumed by patients aged 6-36 months (222).  
Clostridium difficile is a Gram-positive bacterium that causes colitis by the 
production of toxins. Treatment with metronidazole and vancomycin is effective, but 
there were incidences of recurrence of the disease in some patients (231). The 
pathophysiology of the disease, particularly the recurrence, is not clearly defined. 
Production of spores are considered a contributing factor to the recurrence but no 
conclusions have been derived (149). Re-treatment with antibiotics is usually 
prescribed. The probiotic yeast Saccharomyces boulardii exhibited positive results in 
effectively managing C. difficile infection in mice and humans (231). The probiotic 
prevented the adherence of C. difficile to cells in vitro (238) and also stimulated the 
IgA immune response to toxin A in mice (189). The efficacy of the probiotic in 
inhibiting recurrence of the disease was demonstrated on patients with renal failure, 
whereby 5 out of 7 patients tested showed an improvement (186). In 3 separate 
studies, 8 of 11 adults, 2 of 4 children and 5 of 9 adults were cured from C. difficile 
associated diarrhoea by treatment with L. rhamnosus GG (13, 16, 77).  
Shigellosis, caused by Shigella dysenteriae 1, is a highly contagious infection 
characterized by fever, diarrhoea and bloody mucoid stools (130). Frequency of 
epidemic outbreaks and the fatality rate of young children pose a major concern in 
developing countries. Furthermore, the emergence of strains that are resistant to 
multiple antibiotics, is increasing. Rat studies have proven successful in understanding 
the pathogenesis of the disease and to evaluate the effect of probiotics. A combination 
of L. rhamnosus and L. acidophilus exhibited a protective role in reducing 
inflammation of rat tissue and aid in eliminating infection (158).  
Campylobacter jejuni is a Gram-negative bacterium frequently isolated from 
animal faeces. Infection caused by the organism usually results in enteritis and is 
characterized by abdominal pain, diarrhoea and fever. Food sources contaminated 
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with C. jejuni is one of the most common causes of diarrhoea amongst humans (201). 
Bifidobacterium breve was evaluated for the treatment of C. jejuni induced enteritis in 
133 patients aged between 6 months to 15 years. The strain did not alleviate 
symptoms, but reduced the number of pathogens detected in the faeces and shortened 
the duration of diarrhoea (242). A combination of L. acidophilus, L. fermentum, L. 
crispatus and L. brevis was successful in completely eradicating the pathogen in 
different sections of a simulated chicken digestive system (30).  
The antagonistic effect of lactobacilli on E. coli is frequently used to select 
potential probiotic strains (39). A strain of L. salivarius suppressed the growth of E. 
coli in the gut of new born rats (39). Similar results were obtained with cultures of L. 
acidophilus and L. lactis in new born pigs (118, 165). In addition to lactobacilli, B. 
thermophilum, B. pseudolongum and E. faecium C63 were successful in protecting 
pigs against E. coli induced diarrhoea (110, 247).  
Prolonged treatment with antibiotics such as clindamycin, cephalosporin and 
penicillin disturb the endogenous bacterial flora which facilitates abnormal 
proliferation of opportunistic enteropathogens (172). This imbalance in normal gut 
microflora causes diarrhoea commonly referred to as antibiotic associated diarrhoea 
and occurs in about 20% of treated patients (172). Probiotic cultures of L. rhamnosus 
GG (180), B. longum (40) and E. faecium SF68 (25) were administered to patients on 
antibiotic treatment. A significant decrease in the incidence of antibiotic associated 
diarrhoea was reported in the double-blind placebo controlled trials. C. difficile is 
usually present in the intestine at very low levels and antibiotic treated patients may 
become susceptible to the associated infection (172). Diarrhoea may progress to 
pseudomembranous enteritis and recurrence of the disease may occur. S. boulardii 
was concomitantly consumed with vancomycin and recurrence of the disease was 
considerably reduced compared to the placebo group (148). The probiotic produces 
proteolytic enzymes that digests toxin A or B of the pathogen. This important 
mechanism of action prevents adsorption of the toxin to receptors on the intestinal 
mucoepithelium (148).  
Probiotics have also demonstrated their efficacy in the treatment of traveller’s 
diarrhoea which may be acquired by the ingestion of contaminated food or water. 
Occurrence of the disease is more prevalent in residents from developed countries 
travelling to developing countries. Most of the reported cases (80-85%) have been 
initiated by bacterial pathogens such as enterotoxigenic E. coli (ETEC) and 
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Campylobacter jejuni (88, 255). Due to the diversity in the cause and etiology of the 
disease, antibiotic therapy proves complex and controversial. A probiotic supplement 
containing S. boulardii, L. acidophilus and B. bifidum provided a safe and effective 
alternative in the prevention of traveller’s diarrhoea in 12 controlled clinical trials 
(147).  
Helicobacter pylori causes gastritis and peptic ulcers and is thus considered to be a 
risk factor for gastric cancer (92). Presence of the organism in most individuals is 
usually asymptomatic. However, the organism has been associated with a high 
mortality rate (137). Numerous in vitro studies have verified the ability of various 
lactobacilli or their metabolic products to eliminate or inhibit the pathogen. Some of 
these strains include L. acidophilus CRL 639, the metabolic product lactisyn (133), L. 
johnsonii LA1 (153) and L. salivarius WB1004 (3). Some researchers have claimed 
that the high lactate production of lactobacilli is the major factor for eradication of H. 
pylori (3, 154). Other researches have shown inhibitory effects by the production of 
antibacterial compounds such as microcin. L. johnsonii LA1 not only destroyed free-
floating H. pylori cells but also those attached to epithelial cells in vitro (153). 
Mechanisms of competitive adhesion have been demonstrated by some strains of L. 
reuteri. These strains contain a surface glycolipid binding protein that is homologous 
to that of H. pylori and competes for receptor sites on the host (163). L. salivarius 
WB1004 inhibited the adhesion of H. pylori to human and mouse gastric epithelial 
cells (109). In human trials, treatment with a probiotic strain of L. acidophilus resulted 
in a higher percentage of eradication of the pathogen compared to groups treated with 
antibiotics (27). Supplementation of fermented milk with the probiotic L. casei DN-
114 001 inhibited proliferation of H. pylori in children with gastritis (234).  
The gastrointestinal barrier is composed of physical (epithelial cells with the 
mucosal layer) and functional (immune cells) components (51). This barrier plays a 
fundamental role in restricting the colonisation of pathogens, prevents the 
translocation of foreign antigens and regulates the antigen specific immune response 
(208). Any disturbance in this impressive array of intestinal defences will result in gut 
barrier dysfunction and inflammation (101). Probiotics have displayed various 
mechanisms in counteracting inflammation and these include degradation of enteral 
antigens, stabilisation of normal microflora during infection and reduction in the 
production of inflammatory mediators (101). During infection, the healthy host-
microbe interaction is compromised and an imbalance in the intestinal microflora is 
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accompanied by inflammation (51, 101). Counteracting infection, thereby reducing 
the generation of antigens and restoring microbial balance, constitutes the rationale for 
probiotic therapy (101). Probiotics are thus useful for the treatment of inflammatory 
bowel diseases (IBD) such as irritable bowel syndrome (IBS), Crohn’s disease and 
ulcerative colitis (101). Interleukin-10 (IL-10) is a pleiotropic molecule involved in 
anti-inflammatory reactions. IL-10 gene deficient mice develop chronic colitis similar 
to that observed for patients with Crohn’s disease. Increased permeability as assessed 
by mannitol flux was observed in IL-10 gene deficient mice in an Ussing chamber. 
Permeability was eliminated after 4 weeks of treatment with the probiotic combination 
VSL#3 which contains Bifidobacterium spp., Lactobacillus spp. and Streptococcus 
spp. (136). The probiotic effect was mediated by a soluble proteinaceous component 
as similar results were observed by treatment with the VSL#3 cell-free culture 
medium. The effect was abolished after treatment of the culture medium with 
proteinase, indicating the involvement of a protein molecule in mediating the response 
(136).  
L. bulgaricus was the first probiotic reported to possess anti-tumour properties 
(19). β-glucuronidase, β-glucosidase, azoreductase and nitroreductase, enzymes 
produced by enteric bacteria, are involved in the production of carcinogens from 
innocuous complexes. Probiotic bacteria mediate anticarcinogenic properties by 
suppressing bacteria that produce these enzymes and degrade carcinogens in the 
gastrointestinal tract. A reduction in the release of these enzymes were observed in 
individuals that consumed milk fermented with Lactobacillus spp. and 
Bifidobacterium spp. (22, 73). Nitroreductase is responsible for the production of N-
nitrosamine, which is a carcinogen. Degradation of N-nitrosamine was observed by 
various Lactobacillus spp. (198) and a decrease in the production of the enzyme was 
observed in human subjects after consumption of fermented milk containing L. 
acidophilus (71). Oral administration of carcinogens N-methyl-N’-nitro-N-
nitrosoguanidin (MNNG) and 1,2 dimethylhydrazine (DMH) resulted in DNA damage 
of gastrointestinal cells in rats within 24h. Consumption of L. casei 8h before 
exposure to the carcinogens prevented DNA damage (185). It is hypothesized that 
LAB metabolites are involved in anticarcinogenic effects as heat treatment of L. 
acidophilus resulted in loss of protection against the carcinogens (MNNG) and 
(DMH) (185).  
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LAB are also implicated in having anticholesterolaemic effects. Probiotics can 
assimilate cholesterol for their own metabolism, thereby reducing cholesterol levels 
and improve cardiovascular health (232). The serum cholesterol levels in rats fed with 
skim milk fermented with L. acidophilus were significantly lower than that of rats fed 
with untreated skim milk (82). It was suggested that bacterial metabolites present in 
fermented milk prevented cholesterol metabolism by the body (82). Direct 
assimilation of cholesterol in the growth medium was demonstrated for L. acidophilus 
(66). It was later suggested by some researchers that assimilation occurred as a result 
of cholesterol precipitation in laboratory media, at different pH. This was revealed by 
in vitro assays performed at pH 6.0 and lower (115). However, feeding trials with L. 
acidophilus considerably reduced the serum cholesterol levels of pigs fed with 
cholesterol (66).  
There is also evidence for the therapeutic role of probiotics in alleviating high 
blood pressure. It was proposed that the proteolytic action of probiotic bacteria on 
casein during milk fermentation facilitates the production of bioactive peptides that 
may suppress the blood pressure of hypertensive individuals (235). This theory was 
proven on studies conducted on hypertensive rats (167) and a clinical trial on humans 
(86). Tripeptides, isoleucine-proline-proline and valine-proline-proline, identified as 
by-products of milk fermentation by Saccharomyces cerevisiae and L. helveticus, have 
been recognized as the active compounds for alleviating high blood pressure. The 
compounds function as angiotensin-1- converting enzyme inhibitors (86, 167). Calpis, 
a Japanese company has produced a functional food product called Ameal-S, based on 
this technology (207).  
The beneficial role of probiotics has also been exemplified in improving the 
digestion of humans and animals. In the former, the most widely explored aspect has 
been the compensation for lactase in lactose intolerant individuals (51). These 
individuals possess a congenital deficiency for the enzyme β-galactosidase in the 
brush borders of the small intestine (197). As a result, undigested lactose proceeds to 
the colon where it is utilized by colonic bacteria resulting in abdominal discomfort 
and diarrhoea (140). The presence of LAB in yoghurt generates the lactase enzyme 
either in culture or during growth in the gastrointestinal tract. This enzyme facilitates 
lactose digestion and thus eases the symptoms in lactose intolerant individuals (140). 
These individuals digested lactose more efficiently in yoghurt preparations as 
compared to the same amount of lactose in milk (62). This was determined by the 
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hydrogen breath analysis method, as a measure of hydrogen secretion in the breath is 
correlated with colonic fermentation and lactose maldigestion (125). Among the first 
clinical trials conducted with lactobacilli, the associated relief in constipation was 
observed. Supplements of L. acidophilus favourably enhanced the bowel function of 
constipated patients (78). LAB are also valuable generators of vitamins, especially the 
B complex vitamins as well as enzymes that aid in digestion (140).  
 
2.5 Lactobacillus plantarum 
2.5.1 Ecological diversity 
The genus Lactobacillus encompasses over one hundred different species that 
inhabit a range of environmental niches (229). However, only a limited number of 
species are encountered in fermented foods and in the human gastrointestinal tract and 
one of them includes L. plantarum (28). One of the most significant lactic acid 
bacterial strains to be incorporated in meat (37, 65), plant, vegetable (111, 179, 199, 
227, 249) and dairy fermentations is L. plantarum (49), indicating the versatile nature 
of this bacterium.  
Whole genome sequence data of L. plantarum WCFS1 revealed a large number of 
genes encoding surface-anchored proteins and regulatory functions (116). The genome 
contains two lifestyle adaptation islands which encode proteins responsible for the 
adaptation of the organism to its environment. The first is 3080-3260 kb and encodes 
proteins solely involved in sugar transport, metabolism and regulation. The second is 
2600-3000 kb and encodes a large number of extracellular peptides. This valuable 
information indicates the incredible ability of this microorganism to exist and adapt to 
a vast range of habitats (17, 116)The ecological diversity of this microorganism is 
further justified by the genome size (approximately 3 308 274bp), one of the largest 
known genomes of lactic acid bacteria (116) 
 
2.5.2 Probiotic properties 
The numerous reports documenting the use of L. plantarum in various food 
fermentations, functional foods as well as its natural occurrence in the human 
gastrointestinal tract, provides an indication on the general safety of the 
microorganism. However, this cannot be accepted as a general consensus and the 
possible role in infection needs to be thoroughly evaluated for each new strain prior to 
its use as a probiotic. One of the concerns of L. plantarum has been the association 
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with infective endocarditis (221). However, the number of cases implicating the role 
of L. plantarum in the disease is very limited. Furthermore, problems were associated 
with obtaining a positive isolate (98). The possible role in infective endocarditis is a 
trait shared by other lactic acid bacteria and is not solely associated with L. plantarum 
(98). 
The correlation between bacterial translocation and septic morbidity is increasing 
(202). This necessitates the need to examine the passage of bacteria across the 
intestinal barrier and its isolation from sterile locations such as blood (204). Research 
conducted on L. plantarum NCIMB, the human saliva isolate, indicated no adverse 
translocation across the intestinal barrier of mice. Conversely, administration of the 
strain reduced the translocation of endogenous microbiota in mice suffering from 
colitis (184). In another study, L. plantarum 299V did not influence bacterial 
translocation and postoperative septic morbidity in surgical patients (150). Intravenous 
injection of L. plantarum 299V to rats did not result in bacteremia as no detection of 
the probiotic was observed in the heart and the blood, 96 h after injection. This 
indicates that even if bacterial translocation took place, no infection occurred, 
illustrating the safety of the probiotic (1). Another recent report showed that in 66 of 
100 000 bacteremia cases, 48 isolates were confirmed to be Lactobacillus strains of 
which 26 were L. rhamnosus. L. plantarum was not involved in any of the bacteremia 
cases (205). 
Various inhibitory compounds that exhibit hostile activity against a range of 
Gram-positive, Gram-negative and fungal species, are produced by L. plantarum 
strains. Some plantaricins reported to date include plantaricin A (45), plantaricin B 
(253), plantaricin C (74), plantaricin F (58) and plantaricins S and T (104). Some 
plantaricins display a broad antimicrobial spectrum against Gram-positive and Gram-
negative bacteria. Two examples include bacteriocins ST26MS and ST28MS, 
produced by L. plantarum strains isolated from molasses (241). Novel antifungal 
compounds were isolated from the culture filtrate of the sourdough L. plantarum 
strain 21B. Thin layer chromatography and spectroscopic analysis indicated antifungal 
compounds such as phenyllactic and 4-hydroxy-phenyllactic acids which almost 
completely inhibited various Eurotium, Penicillium, Endomyces, Aspergillus, Monilia 
and Fusarium spp. (121). Novel and diverse inhibitory compounds produced by L. 
plantarum strains are continually being reported, depicting the importance of this trait 
for probiotic potential. 
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Stimulation of the immune system facilitated by adhesion of the probiotic, is 
another valuable consequence of probiotic administration. L. plantarum 299V 
increased the production of interleukin-10 (IL-10) by macrophages and T cells (183). 
Rats administered with a combination of L. plantarum and E. coli showed higher 
levels of serum IgA, and IgM and IgA antibody levels against E. coli, in comparison 
to rats that were administered with E. coli alone. These results signify that L. 
plantarum competes with E. coli for intestinal colonisation and plays a pivotal role in 
stimulating the immune system (87).  
The ability of L. plantarum to reduce cholesterol levels was also depicted. Rats 
treated with metabolites of L. plantarum I-UL4, isolated from the culture medium, 
showed significantly lower levels of total plasma cholesterol in comparison to the 
control group (53). Humans with slightly high cholesterol levels showed a decrease in 
both the LDL-cholesterol and fibrinogen levels in the blood after consumption of 
probiotic 299V (24). Expression of the bile salt hydrolase enzyme (bsh) by L. 
plantarum is proposed to contribute to the lowering of cholesterol levels (169). This 
enzyme hydrolyses bile acids in cholesterol to deconjugated bile salts, which are more 
readily excreted in the faeces as compared to conjugated bile salts (237). The presence 
of this gene in L. plantarum enables the organism to tolerate toxic levels of bile acids 
(36). L. plantarum displays probiotic properties by its ability to survive acid and bile, 
adhere and colonise the gastrointestinal tract, produce antagonistic compounds, and 
have GRAS status, as indicated by the number of investigations conducted on this 
bacterium. 
 
2.5.3 Adhesins of L. plantarum and their role in probiotic potential 
One of the most essential roles proposed for probiotics is the ability to eliminate 
intestinal infections caused by enterotoxigenic E. coli (ETEC), the causative agent of 
travellers’ diarrhoea (190). These pathogenic ETEC strains express type 1 fimbriae 
that interact with mannose receptors on the host cell surface. Mannose specific 
adhesins have been described for L. plantarum and this mechanism of adhesion plays 
an important role in eliminating type 1 fimbriated E. coli by competing for the same 
receptor sites at the epithelial surface (2, 188). Cell surfaces of yeast are covered by α- 
mannoside oligosaccharides. Deletion of the mannose specific adhesin (Msa) of L. 
plantarum prevented the organism from agglutinating yeast cells (188). In addition, 
Msa (LP1229) contains three mucus binding domains, indicating the importance of 
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this molecule for mediating adhesion of the microorganism to host surfaces (188). 
Factors involved in the binding of L. plantarum Lp6 to rat intestinal mucus indicated 
mannose specific adhesins to be the most significant factor (230). Mannose adhesion 
is possibly one of the most significant probiotic traits of L. plantarum.  
Chemical and enzymatic pre-treatments of 31 strains of L. plantarum indicated 
that lectin-like adhesins and proteinaceous cell surface structures mediate adhesion of 
the strains to Caco-2 cell lines and mucin (236). Adhesion of L. plantarum strains 
299V, CBE, BMCM12, Col4S and T25 were strongly inhibited when cells were 
treated with trypsin, lithium chloride and methyl-α-D-mannoside (236). A large 
number of extracellular proteins (~223) are encoded by the L. plantarum genome. Of 
these proteins, a large proportion contains domains involved in the attachment of the 
cell to its surface (17). Three domains are involved in the adherence to collagen, 1 
with a chitin binding domain, 1 with fibronectin and 7 involved in the adhesion to 
mucus (17). These data reveal the high adhesive ability of this microorganism, an 
important characteristic for potential probiotics. This characteristic is verified by the 
ability of the probiotic L. plantarum strain 299V to adhere to rectal mucosa of healthy 
as well as critically ill patients on antibiotic treatment (114). Strain 299V further 
demonstrated that pre-treatment with the probiotic prevented intestinal permeability in 
rats, induced by E. coli, supporting the concept that adhesion of probiotics exert 
beneficial effects in the gut (138).  
 
2.5.4 Implications in health 
Due to their excellent probiotic potential, L. plantarum strains 299 and 299V have 
been incorporated in a number of human trials. Table 1 outlines the effect of L. 
plantarum on the health status of healthy volunteers and patients as assessed by in 
vivo studies. A considerable decrease in Gram-negative anaerobic fecal bacteria was 
observed in healthy volunteers who consumed daily intakes of an oatmeal soup 
containing different strains of lactobacilli. The main Lactobacillus strains that were 
recovered after days 1 and 11 were L. plantarum strains 299 and 299V. This indicates 
survival of gastric transit, prolonged retention and the exceptional ability of this 
microorganism to colonise the gastrointestinal tract, particularly when there is 
competition amongst other strains (105). 
L. plantarum is available as health adjuncts either as capsules or incorporated in a 
drink. A few popular products available as capsules include Plantadophilus, 
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manufactured by New Health Education, Bio-Kult, manufactured by the Finchley 
Clinic and Probion, manufactured by the Healing Arc. The positive effects on human 
health associated with the consumption of L. plantarum is developing into a promising 
field for marketing future strains as potential probiotics and health adjuncts. 
 
Table 1. Effect of L. plantarum on healthy volunteers and patients in various 
trials 
Dosage Duration Number of 
Subjects 
Effect Ref. 
Unknown 13 days 151 Six times reduction in 
fecal enterobacteria 
(111) 
1 x 1010 6 weeks 30 9.6% reduction in LDL-
cholesterol and 13.5% 
reduction in fibrinogen 
(24) 
Unknown 4 weeks 18 Increase in weight and 
improved natural immune 
response in children with 
HIV 
(42) 
5.0 x 1010 38 days 20 1/3 reduction in 
recurrence of Clostridium 
difficile associated 
diarrhoea 
(254) 
2.0 x 1010 4 weeks 40 Reduction in symptoms of 
IBS (abdominal pain, 
bloating and flatulence) 
(170) 
Source: Adapted from De Vries et al., 2005 (43)  
 
2.6 Enterococci as potential probiotics 
2.6.1 Safety of enterococci as potential probiotics 
The use of enterococci as potential probiotics is a very controversial issue due to 
their implication in nosocomial infections and superinfections such as endocarditis, 
bacteremia, urinary tract, intra-abdominal and pelvic infections (57). Further causes of 
concern is the presence of virulence factors such as invasins, haemolysin and the 
resistance to a range of antibiotics (166). Enterococcus faecalis and Enterococcus 
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faecium are the two major species associated with enterococcal infections, with the 
former being accountable for more than 80% of human infections (103). The 
remaining Enterococcus spp., including E. mundtii, are rarely associated with 
infections (164). In addition enterococci are opportunistic pathogens that usually 
cause infection in patients with an existing underlying disease or in 
immunocompromised individuals (161). The potential of these opportunistic 
pathogens to cause disease in healthy humans is highly unlikely. Furthermore, the 
mortality of healthy humans associated with enterococcal infections is extremely low 
(55). Enterococci are ubiquitous lactic acid bacteria that have a long history of safe 
use in various food fermentations such as meat (57), cheese (131) and olives (12). 
They also constitute part of the autochthonous microflora of the GIT of humans and 
animals (57), indicating their general safety. 
The use of enterococci as potential probiotics will probably always remain 
controversial. It is thus imperative that when an enterococcal strain is to be considered 
as a probiotic, rigorous in vitro evaluation will have to be conducted which should be 
confirmed by in vivo analysis. The detection of any virulence genes or antibiotic 
resistance genes is of cardinal importance and it should be noted that these traits are 
strain specific. The presence of these genes ought to be carefully evaluated, 
particularly since the transfer of these genes to other strains forms part of the main 
controversy for using enterococci as probiotics (55). 
 
2.6.2 Enterococcal adhesins 
Enterococci are gastrointestinal commensals, which reflects the need for adhesive 
components to promote binding to eukaryotic tissue and facilitate colonisation. This 
ensures survival, as non-binding enterococci would be eliminated with the high flow 
rates of the lumen (103). It is therefore, not surprising that evolutionary pressure for 
colonisation and survival has resulted in organisms capable of expressing more than 
one type of adhesin (85). The concept of multiple adhesins in Gram-negative bacteria, 
especially in the Enterobacteriaceae family has been recognised for over 20 years. 
However, this concept of multiple adhesins has been extended to Gram-positive 
bacteria and is suggested to be implicated in specific purposes, not necessarily 
pathogenic (46, 85). Adhesion of a pathogen to host tissue is considered the first step 
to elicit infection (9). However, in the case of probiotics, adhesion is considered as a 
positive response in assisting the host in eliminating possible infectious agents. Hence, 
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the mechanisms of adhesion and molecules that mediate this function play an 
important role in establishing if the outcome of adhesion is possibly pathogenic or 
probiotic. The aggregation substance, enterococcal surface protein and surface 
carbohydrates are adherence factors of enterococci which are considered to be 
virulence factors. In contrast to the detailed characterization of these adhesins, limited 
research has been conducted on other adhesion mechanisms in enterococci (103).  
A few factors need to be taken into consideration when investigating the role of 
adhesion of enterococci as a pathogenic trait. During an infectious disease, pathogens 
colonise host tissue by engaging their surface bound adhesins with host receptors. In 
certain instances, recognition of host receptors is specific in targeting a particular 
tissue or organ (90). For example, Bordetella pertusis is capable of discriminating 
between cilia and macrophages and between humans and other mammalian cells 
(212). Hence, if adhesins have a specific target site it can be considered significant in 
playing a role in pathogenesis (57). Certain adhesins are reported to be toxins by 
interacting with a repertoire of host cells. On the one hand adhesins mediate 
attachment of the bacterium whilst at the same time induce cellular intoxication by 
introducing the enzymatically active toxic subunit (90, 209). Molecular and 
physiological characterization of adhesins are imperative in determining its effect on 
the host. Plasmids usually encode genes conferring additional characteristics to an 
organism. They are known to harbour virulence genes which are transferred between 
strains by elements such as transposons. The presence of a gene encoding an adhesin 
on a plasmid may be considered a virulence factor, as it could be transferred to other 
strains (103). Hence, the location of the adhesin gene is critical when investigating 
adhesins in enterococci. 
 
2.6.2.1 Aggregation substance 
Aggregation substances (AS) in E. faecalis are surface bound adhesins encoded by 
pheromone induced-plasmids. Aggregation substances are produced in response to sex 
pheromones which are small peptides excreted by plasmidless recipient strains of E. 
faecalis (48). Aggregation substances cause clumping, altering the surface of the 
donor bacterium which facilitates plasmid transfer (48). In eukaryotes, AS mediates 
the adhesion of E. faecalis to cultured renal tubular cells and an Arg-Gly-Asp-Ser 
amino acid motif is thought to be involved in the binding (119). This amino acid motif 
is also present in fibronectin and facilitates binding to eukaryotic receptors known as 
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integrins (119). E. faecalis cells expressing AS were internalised by enterocytes to a 
higher degree as compared to non-expressing mutant strains (174). Electron 
micrographs indicated that AS interacted with enterocyte microvilli. Localisation of 
enterococci occurred within membrane bound vacuoles in the cytoplasm, indicating 
that AS is an important virulence factor (174). 
 
2.6.2.2 Enterococcal surface protein 
The enterococcal surface protein (Esp) is a chromosomally encoded adhesin (55). 
Esp is a 202kDa bacterial surface protein that is composed of repeating units at the 
central core, a slightly divergent C-terminal cell wall anchor domain and a globular N-
terminal domain (219). The number of central repeats between E. faecalis isolates 
were found to vary between 3 and 11 and is hypothesised to serve as a retractable arm 
extending the N-terminal globular domain through the cell wall to the surface (219). 
Esp contributed to the colonisation of E. faecalis in the urinary tract of mice. 
However, no histopathological changes were induced to mice tissue upon adhesion of 
the strain (220). Esp also plays a role in adherence to abiotic surfaces and biofilm 
formation by increasing cell surface hydrophobicity. The protein exhibits 
characteristics of surface protein receptors designated “microbial surface components 
recognising adhesive matrix molecules”(MSCRAMMs) which mediates binding to 
extracellular matrix proteins and promotes colonisation (243). Incidence of Esp was 
shown to be higher in clinical isolates of E. faecalis compared to isolates from healthy 
individuals (219). 
 
2.6.3 Implications of enterococci in health 
Enterococci are known to produce enterocins which generally belong to the class 
II bacteriocins (57). They exhibit antimicrobial activity against other enterococci, 
strains of Listeria monocytogenes (68) and Clostridium spp. (56). Enterocin AS-48, 
produced by E. faecalis S-48, was the first enterocin purified to homogeneity (63, 
142). Enterocin ST4SA, produced by E. mundtii ST4SA, is resistant to treatment at 
80ºC for 90min and incubation in MRS broth at pH 1.0 to 10.0. The bacteriocin is also 
active against a number of food-borne pathogens including Bacillus cereus, 
Clostridium sporogenes, Enterococcus faecalis and Listeria monocytogenes (117). 
One particular study showed the inhibitory activity of mundticins against Listeria 
innocua and two Salmonella enteritidis strains isolated from cheese. This was one of 
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the very few studies testing the antimicrobial activity of enterocins against Salmonella 
spp (50). The use of these microorganisms for treatment of food-borne infections 
denotes an important implication for health. 
E. faecium SF68 is a probiotic strain that has in vitro inhibitory activity against E. 
coli, Salmonella spp., Shigella spp. and Enterobacter spp. Strain SF68 was selected as 
a probiotic as it is a commensal of the human intestine, has a short lag phase and 
generation time and is moderately resistant to antibiotics. Additional characteristics 
include tolerance to low pH and resistance to bile salts (11, 126). E. faecium SF68 is 
used to treat diarrhoea and was successful for the treatment of enteritis in adults and 
children (11, 126). Further health benefits associated with probiotic SF-68 includes 
the reduction of blood ammonia and improving the mental state and psychometric 
performance of patients with hepatic encephalopathy. It was suggested that SF-68 
modified the intestinal microflora, thereby reducing blood ammonia levels and the 
associated disorders in these patients (132). 
 
2.7 Adhesion studies 
Initial experiments conducted to gain insight on components that mediate adhesion 
of lactobacilli indicated that protein and carbohydrate molecules play a substantial 
role in this aspect (2, 245). Boiling, autoclaving and enzymatic treatment with trypsin 
and pepsin reduced the adhesion of L. acidophilus LA1 to intestinal mucus and L. 
rhamnosus GG to intestinal mucosal cells, respectively (245). The importance of 
protein molecules in mediating adhesion was demonstrated after treatment of different 
Lactobacillus spp. with proteases, as adhesion was significantly reduced in these 
strains (38, 81). The interaction of carbohydrate moieties in cell attachment was 
depicted after treatment of different lactobacilli with metaperiodate, as this causes 
oxidation of carbohydrates. Treatment with metaperiodate decreased adhesion of the 
lactobacilli to cell lines (81).  
Various mechanisms have been described for the anchoring of proteins to the 
surfaces of Gram-positive bacteria (Fig. 2.1). The cell envelope of Gram-positive 
bacteria is composed of a cell membrane surrounded by a peptidoglycan (PG) layer 
and cell wall polymers such as teichoic acids, teichuronic acid and other neutral or 
acidic polysaccharides (168, 217, 244). A common anchoring mechanism is the 
sortase-dependent mechanism via the LPXTG-motif (leucine, proline, X represents 
any amino acid, threonine and glycine). Proteins with this mechanism contain a 
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carboxyl terminal LPXTG motif, a hydrophobic region and a tail of charged amino 
acids (a, Fig. 2.1). The LPXTG sequence is covalently linked to the peptide cross 
bridges of PG via a membrane associated sortase enzyme (182, 244). The mucus 
binding protein (MUB) (196), other putative mucus binding proteins (18), cell 
envelope proteases (215) and exoenzymes such as fructosyltransferase (248) are 
lactobacilli surface proteins characterized with this motif. The GW-motif (repeats of 
glycine and tryptophan) was first identified in Listeria monocytogenes but has also 
been described for Lactobacillus spp. (23). Proteins with the GW-motif contain 
glycine and tryptophan repeats in the carboxyl terminus which anchors the protein to 
cell wall techoic acids (107) (b, Fig. 2.1). Proteins with the LysM domain have been 
described for various bacterial species and mediates binding to PG via the C-terminus 
(10) (c, Fig. 2.1). It was thus suggested that this domain binds to a common 
component in PG such as the glycan strands (228). Other mechanisms include the 
direct binding of proteins to the cell membrane via a common cysteine containing 
lipobox (d, Fig. 2.1) (233) or an α-helical transmembrane anchor (e, Fig. 2.1) (44).  
 
Fig. 2.1. Different mechanisms of protein anchoring to the Gram-positive cell surface. 
a: anchoring via the LPXTG-motif; b: anchoring via the GW-motif; c: anchoring via 
the C-terminus of the LysM domain; d: direct binding of proteins to the cell 
membrane via a common cysteine containing lipobox; e: or an α-helical 
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transmembrane anchor. N: amino terminal domain and C refers to the carboxyl 
terminal domain of proteins.  
Molecular characterization of adhesive proteins in lactobacilli have not received 
much attention. Most of the research conducted on adhesion focuses primarily on 
phenotypic aspects such as in vitro adhesion of potential probiotic cells to adhesion 
models such as cell lines (Caco-2 and HT-29) or mucus preparations. Adhesion 
proteins characterized to date includes the mucus binding protein (Mub) (196), mucus 
adhesion promoting protein (MapA) (211), anchorless multifunctional proteins 
elongation factor Tu (EF-Tu) (80) and GroEl (14), surface layer proteins (Slp) (21, 
252) and the aggregation promoting factors (apf1 and apf2) (102, 251).  
 
2.7.1 Mub  
The mucus binding protein is a high molecular mass (358 kDa), cell surface 
protein isolated and characterized from L. reuteri 1063 (196). Strain 1063, isolated 
from the small intestine of a pig, exhibited strong adherence to small intestinal mucus 
preparations of pigs and hens. Treatment of the strain with proteinase K eradicated the 
adhesion to mucus, indicating that binding was mediated by a proteinaceous 
substance. Mub was isolated from the culture supernatant and the surface of strain 
1063, after multiple wash steps. Mub was the first Lactobacillus adhesion protein 
shown to contain the same domain organization as most of the characterized adhesins 
from other Gram-positive bacteria. These include a signal peptide, C-terminal 
anchoring sequences containing the LPXTG domain, repeated regions displaying 
adhesion properties and an N-terminal region, often with an uncharacterized function 
(196). Mub contains unique features, such as being one of the largest bacterial cell 
surface proteins identified, the corresponding Mub gene has two possible translation 
start sites, and the membrane anchor sequence at the C terminus contains a cysteine 
residue. The presence of two types of amino acid residue repeats (MBP-Mub1 and 
MBP-Mub2) and an N-terminal region of >500 amino acids indicates that Mub is a 
multifunctional protein. Inhibition of binding by the glycoproteins fetuin and 
asialofetuin suggests interaction with carbohydrate components in mucus. However, 
this inhibition of binding affected MBP-Mub2, indicating interaction of MBP-Mub1 
with other carbohydrate structures of mucus. Furthermore, binding was shown to be 
pH dependent at just below neutral pH with both repeats having different pH optima. 
These data indicate the adaptation to different niches in the gastrointestinal tract (196). 
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Mub homologues have also been described for L. acidophilus, L. gasseri, L. johnsonii 
and L. plantarum, indicating the importance of this protein for the adherence and 
colonisation of lactobacilli (4). 
 
2.7.2 MapA 
The mucus adhesion promoting protein, MapA, is a cell surface protein isolated 
from L. reuteri 104R, originally thought to be L. fermentum 104R. The mechanism by 
which this protein anchors to the cell surface has not been determined (211). MapA 
has a molecular mass of 26kDa and a theoretical pI of 9.7. MapA shares a high 
similarity with the collagen binding protein, CnBP, of L. reuteri NCIB 11951 and the 
bacterial surface protein, BspA, of L. fermentum. BspA and CnBP are recognized for 
their binding potential to type 1 collagen and fibronectin which are mammalian 
receptors for many pathogens. Hence, these adhesion proteins participate as potential 
antagonistic competitors. In vitro experiments exhibited the ability of purified MapA 
to bind to Caco-2 cell lines and was also responsible for the binding of L. reuteri to 
these cell lines (157). MapA was suggested to aid L. reuteri DSMZ 20016 in 
colonising mice tissue. The best possible probiotic potential of this protein was 
demonstrated by the antagonistic activity against Campylobacter jejuni, by competing 
for the Peb1 receptor on HeLa cells (193). 
 
2.7.3 Elongation factor-Tu and GroEl 
The description of EF-Tu as an adhesion molecule occurred as an attempt to 
distinguish the surface proteins of L. johnsonii (NCC533) La1 that mediated 
attachment to epithelial cell lines or mucin (80). The EF-Tu protein is a GTP binding 
protein that functions during protein synthesis but also plays a role in the adhesion of 
L. johnsonii La1 to human intestinal cell lines and mucus. The importance of the 
protein in mediating attachment was reflected by the ability of the purified protein to 
inhibit binding of strain La1 to mucin by up to 40% (80). EF-Tu of L. johnsonii does 
not possess an identifiable signal sequence and also lacks the first methionine at the 
amino terminal. The protein also showed an apparent lack of the LPXTG 
peptidoglycan anchor motif or a lipoprotein motif, to demonstrate its localization on 
the surface of the bacterium. The presence of EF-Tu on different regions of bacteria is 
well documented. An EF-Tu recombinant molecule bound to HT-29 cells at neutral 
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pH using sCD14 as a ligand. A CD14 dependent pro-inflammatory response was also 
elicited upon adhesion to HT-29 cells (80). 
GroEl is an ‘intracellular’ protein functioning in protein folding. However, the 
protein was identified on the cell surface and the culture medium of L. johnsonii La1 
and binds to mucin and human epithelial cells at acidic pH (14). Probiotic potential of 
this protein in L. johnsonii was demonstrated by the ability to stimulate interleukin-8 
secretion in macrophages and aggregate cells of the gastric pathogen Helicobacter 
pylori (14). EF-Tu and GroEl are referred to as anchorless multifunctional proteins as 
no established signal sequence or anchoring motif is present in their predicted 
sequences (35). 
 
2.7.4 Surface layer proteins  
Surface layers (S-layers) are crystalline structures composed of protein or 
glycoprotein subunits with molecular masses ranging from 40 to 200kDa (225). 
Lactobacilli surface layers are among the smallest known with molecular masses 
ranging from 25 to 71kDa (210). The unique property of lactobacilli S-layer proteins 
is its highly basic nature with pI ranging from 9.35-10.4 (210). This may occur as a 
result of a higher percentage of positively charged amino acid residues (12.5%). 
Glycan structures have been identified from the S-layer proteins of different Gram-
positive bacteria (218). However, lactobacilli S-layers appear to be non-glycosylated 
with only the glycan structure of L. buchneri been reported (143, 162). The amino 
acid composition of lactobacilli S-layer proteins share some degree of homology with 
other S-layers, particularly in the high content of hydrophobic amino acids residues. 
This value ranges from 31.9% to 38.7%, a typical feature of all S-layer proteins (224). 
S-layer protein subunits are non-covalently attached to each other and the cell wall. 
These proteins can thus be extracted from the cell surface by chaotropic agents such as 
guanidine hydrochloride or a high concentration of salts, such as lithium chloride 
(224). A general functional property for all S-layer proteins has not been determined. 
However, proposed functions include protective coats, cell shape determinants, cell 
adhesion and surface recognition and molecule and ion traps (210, 225). S-layer 
protein genes of Lactobacillus spp. that have been cloned and characterized includes 
L. acidophilus (21), L. brevis (252), L. helveticus (26) and L. crispatus (223). S-layer 
proteins have also been described for L. amylovorus (20), L. buchneri (64), L. 
gallinarum (143), L. kefir and L. parakefir (144). However, their genes have not yet 
Stellenbosch University http://scholar.sun.ac.za
  
30
been sequenced. The functional role of lactobacilli S-layers are poorly characterized 
with the only proposed function being attachment to various surfaces. Location of the 
adhesive domain of the S-layer protein has been described for L. brevis ATCC 8287 
(SlpA) and L. crispatus JCM 5810. The receptor binding domain of L. brevis was 
established in the N-terminal region of SlpA comprising of amino acid residues 96 to 
176 (97). Binding to fibronectin was also proven to be mediated by the N-terminal 
domain consisting of amino acid residues 96 to 245 (97). In L. crispatus the N-
terminal section of the Slp (CbsA) adhered to collagen and laminin, components of the 
subintestinal extracellular matrix (7). 
 
2.7.5 Aggregation promoting factors 
Aggregation promoting factors (APF) are surface proteins described for L. 
johnsonii and L. gasseri. These proteins contribute to the aggregation phenotype of 
these strains and are thus designated accordingly. The amino acid compositions, 
physical properties and genetic organization of these proteins are similar to the S-layer 
proteins of other lactobacilli, suggesting a similar role in these species. APF 
demonstrate a highly alkaline iso-electric point and display important features 
associated with the more typical S-layer proteins of other lactobacilli. These proteins 
contain all the necessary characteristics exhibited by surface proteins, such as limited 
sulfur containing amino acid residues, high content of serine and threonine and a high 
content of hydrophobic amino acids. These proteins can be removed by treatment with 
LiCl, indicating anchorage to the cell wall by electrostatic or specific non-covalent 
interactions. The APF proteins of both species are encoded by two tandem genes, 
separated by a short intergenic region. A possible explanation for the presence of two 
genes may be attributed to the fact that these organisms encounter various habitats and 
competition for substrates, which may facilitate selective pressure for APF variation. 
The 3’ segment of the corresponding genes are almost identical indicating possible 
functionality of the C-terminal region in anchorage of the APF protein to the 
underlying cell wall. APF was shown to be essential for maintaining the cell shape of 
L. gasseri (102, 251).  
 
2.8 Mechanisms of adhesion 
Protein molecules, (38, 80, 81, 196, 211) lipotechoic acids and mannose residues 
(2, 79) act as major adhesins. This illustrates the importance of receptor mediated 
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binding interactions that occur between probiotics and the host cell. The ability of 
certain strains to exhibit strong adherence is an indication that these strains contain the 
necessary receptors to recognize host tissue receptors. Adhesion of probiotic 
microorganisms to intestinal mucus revealed no changes to mucus derived from 
subjects of different ages. The data indicated no change in the availability of receptors 
for these strains, clarifying the mechanism of receptor mediated adhesion (177). The 
different mechanisms of binding and recognition of certain receptors is further 
justified by the binding of L. acidophilus LA1 to mucus secreted by the HT-29 cells, 
whereas its adherence to Caco-2 cells occurs via a proteinaceous adhesion promoting 
factor (15). 
Other mechanisms such as electrical charges and hydrophobic interactions may 
also contribute to the binding of lactobacilli to host tissue. The Slp confers 
hydrophobicity to a cell. However, adhesion to hydrophobic surfaces does not always 
proceed according to expectations as hydrophobic strains do not always adhere to 
hydrophobic surfaces as predicted by surface thermodynamics. One study 
investigating the adhesion of Lactobacillus spp. to silicone rubber and glass showed 
that certain strains exhibiting hydrophobic properties, such as L. acidophilus 4356 and 
L. fermentum B54 adhered in higher proportions to hydrophilic glass than to 
hydrophobic silicone rubber. It was suggested that other factors play a more 
significant role in adhesion to various surfaces as compared to the interfacial free 
energies (155). Other studies also indicated no correlation between cell surface 
hydrophobicity and adherence to intestinal mucus. Highly adherent bacteria 
demonstrated fairly low surface hydrophobicities. These researchers stated that cell 
surface hydrophobicity was not an accurate measure of adhesive potential and should 
not be used as an appropriate marker for potential adhering microorganisms (177, 
214). 
The adhesion to intestinal cell lines provides a good indication of the adhesive 
properties of a strain. However, it may not take into account the adhesion to the mucus 
layer covering the intestinal cells (176). Intestinal mucus plays a significant role in 
maintaining a barrier between the beneficial and pathogenic bacteria. Mucus serves as 
a medium for the adhesion of commensals whilst preventing the binding of harmful 
bacteria (171). Mucus is a viscous, high molecular weight material secreted by goblet 
cells (213). It is composed of mucin which is a glycoprotein characterized by a high 
molecular weight, high carbohydrate content and O-glycosidic bonds between N-
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acetylgalactosamine and either serine or threonine in the peptide backbone (54). 
MUC2 and MUC3 are the predominant genes encoding mucin in humans. MUC2 is 
expressed in goblet cells of the small and large intestine and is the main mucin 
component present in the colon (31). MUC3 is more prevalent in the small intestine 
and is secreted by goblet cells and enterocytes (31). Mucus serves a dual function, it 
may prevent the adhesion of pathogenic bacteria by forming a gel on the intestinal 
surface, thereby protecting the intestinal cells, but may also serve as a nutrient source 
and matrix for colonisation of probiotic bacteria (171).  
The adhesion of Lactobacillus strains to intestinal epithelial cells in vitro up-
regulated the MUC3 gene, stimulating the production of mucus (134). The up-
regulation of mucin encoding genes, particularly during enteric infections is another 
important mechanism of action by probiotics (93). Probiotic bacteria stimulated the 
production of mucus upon adhesion to adenocarcinoma cell lines. L. plantarum 299V 
adhered to HT-29 cells, which increased the transcription and secretion of MUC2 
mucin. Similarly, an increase in MUC3 mucin production was observed upon 
adhesion of L. rhamnosus GG to Caco-2 cell lines. These probiotic strains proved 
efficient in inhibiting the adherence of an enteropathogenic E. coli strain. It was 
proposed that the ability of these probiotics to hinder pathogenic colonisation was 
mediated through the ability to increase expression of MUC2 and MUC3 (135, 146). 
However, the molecular mechanisms underlying the adhesion or stimulation of mucin 
expression is still unclear. It is still uncertain if mucin stimulation by probiotics are 
facilitated by the activation of intestinal cells by specific molecules or by stimulation 
of the immune system (213). The mucus layer, colonisation by probiotics and 
subsequent stimulation of the mucus genes are all mechanisms that maintain epithelial 
integrity and prevent the translocation of antigens and bacteria from the lumen 
content. Damage of the epithelial lining and intestinal permeability ultimately leads to 
pathogenesis in many circumstances (138). 
Lipotechoic acid (LTA), a molecule associated with the surface of L. johnsonii 
La1 participated in the attachment to Caco-2 intestinal cells and further demonstrated 
an immunomodulatory effect on gut homeostasis. Competitive experiments also 
revealed that LTA was not the only molecule involved in the binding to intestinal 
epithelial cells. This is a further demonstration on the importance of receptor mediated 
adherence for the specificity of adhesion (79).  
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2.9 In vitro adhesion models 
In vitro model systems have proved efficient for providing a good measure on the 
adhesive ability of a potential probiotic. Tissue culture cell lines and mucus 
preparations are the most frequent in vitro models utilized. HT-29 and Caco-2 cell 
lines are the most commonly used for this purpose as these cells are able to 
differentiate and express morphological and physiological characteristics that closely 
resemble human enterocytes (246). The competence of HT-29 cells was evaluated 
when cells were grown in the presence of methotrexate. The cells differentiated into 
goblet cells and secreted mucus. Antibodies raised against the mucus reacted with 
normal human gastric and colonic mucus designating the close proximity of these 
cells (124). HT-29 cell lines provided valuable information on the adherence 
mechanisms of L. plantarum. Binding of L. plantarum strains to HT-29 cells were 
inhibited by methyl-α-D-mannoside providing evidence for a mannose specific 
adherence mechanism for this binding (2). HT-29 cell models were also taken a step 
further into understanding gastrointestinal immune stimulation by the adhesion of 
probiotics. Binding of L. casei 3260 and L. rhamnosus GG to the colonic cell line 
increased Th1 type cytokine levels and decreased Th2 type cytokine levels. Balancing 
of the Th1/Th2 cytokine level may prove valuable for cancer treatment by probiotics. 
However, this effect is critically dependent on the binding capacity of the probiotic to 
the cancer cell (122).  
The specific adhesion of some strains to Caco-2 cell lines illustrates the 
importance of employing this cell line as an in vitro adhesion model. L. rhamnosus 
LC-705 was shown to efficiently bind to Caco-2 cells, whilst the adhesion to intestinal 
mucus was very poor. These observations indicate that certain strains possess specific 
receptors for binding to this cell line. It was also suggested that the availability in the 
amount of certain receptors may also play a crucial role (123). In addition to the 
utilization of this cell line in establishing the adhesive properties of potential 
probiotics, it was also successfully employed in recognising the elongation factor Tu 
as a novel adhesin like factor in L. johnsonii LA1 (80). 
The mucus layer covering epithelial cells serves as an important site for 
colonisation and may also contain specific receptors required for this purpose. The use 
of mucus as an in vitro adhesion model also proves important. An accurate source of 
mucus can be obtained from intestinal scrapings of desired sources. However, it may 
be difficult to obtain mucus from human tissue which led to the isolation of human 
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mucus from fecal samples. This serves as a very practical source, particularly for 
studying adhesion at an individual level. However, this form of mucus is easily 
degradable and important measures should be undertaken to ensure proper analysis 
(175). Alternatives include mucus derived from animal sources which also serves as a 
useful and convenient method of analysis. The addition of pig intestinal mucus to 
MRS growth medium reflected the binding activity of various L. reuteri strains. The 
binding activity of poorly adherent strains were significantly increased after growth in 
the mucin supplemented medium (108). A comparative study observing the adhesion 
of LAB to diseased and healthy human intestinal mucosa revealed that all the tested 
strains adhered more efficiently to intestinal mucus as compared to whole tissue, 
emphasizing the importance of this in vitro model (178). 
 
 
Fig. 2.2. In vitro adhesion model illustrating the adhesion of L. fermentum to chicken 
epithelial cells. Adhesion was observed using phase contrast microscopy after cells 
were stained with 0.5% crystal violet (129). 
 
2.10 In vivo adhesion models 
Data obtained by in vitro testing has proven its functional and practical use, 
particularly in obtaining valuable preliminary information on the properties of a 
potential probiotic. However, in vitro testing does not provide an accurate 
representation of conditions in vivo, which is imperative for the safety evaluation of a 
potential probiotic. Strains that exhibit strong adherence in vitro do not necessarily 
colonise the gut in vivo. In some situations, non-adhesive strains may still influence 
pathogenic colonisation and microbial changes, by the production of antimicrobial 
compounds (176). This necessitates the need for in vivo analysis. Exposure to bile, 
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pancreatic juice and varying pH are some of the digestive stress conditions that 
probiotics need to overcome to efficiently colonise the gut. Pretreatment of potential 
probiotic strains to canine jejenal chyme dramatically reduced adhesion of the strains 
to intestinal mucus. It was thus suggested that the selection criteria for adhesion of 
probiotics should be altered to include “adhesion after exposure to digestive factors”. 
It was also emphasized that adhesion properties should be further assessed after transit 
through an intestinal or animal model (192). The use of animal models for assessing 
the adhesive capability of an organism has most often analysed cell counts from fecal 
samples. This provides an effective indication on the ability of the organism to 
colonise as well as the duration of colonisation (128).  
Rat and mouse models are more prevalent choices for the adoption of in vivo 
testing and have been incorporated in numerous trials (138, 184, 258). These models 
are often used for evaluation of the safety and efficacy of a potential probiotic in the 
gut. Prior to the incorporation of a probiotic in food and pharmaceutical applications, 
every concern surrounding its safety for human consumption needs to be tested and 
resolved. One of these main concerns is bacterial translocation and the possibility of 
septicemia, particularly since there have been some reports on the association of 
lactobacilli with bacteremia (204). Although the causative agents of these diseases 
were unlikely to be LAB, each new potential strain introduced to the market needs to 
be thoroughly assessed. Rat and mouse models provide an accurate and 
comprehensive means for this purpose. They have been successfully utilized in a 
number of trials to evaluate the safety potential and gain vital information on probiotic 
properties. Criteria used to examine any deleterious effect of a probiotic includes any 
adverse effect on the general health status of the animal, alterations in the feed intake 
and body weight, changes in differential blood cell count and changes in intestinal 
mucosal morphology (villus height, crypt depth, epithelial cell height and mucosal 
thickness). Bacterial translocation can be assessed by the detection of any viable 
bacteria recovered from blood and tissue samples such as the mesenteric lymph nodes, 
liver and spleen (95, 184, 258). β-glucuronidase, β-glycosidase, azoreductase, 
nitroreductase and nitrate reductase are bacterial enzymes that have been implicated in 
generating mutagens and carcinogens (197). Measurement of the fecal enzymatic 
content of these enzymes is another safety evaluation trait examined in these models. 
In conclusion, in vitro assays are extremely useful for the pre-selection of potential 
probiotic strains. However, the proof of efficacy of the probiotic can only be evaluated 
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through in vivo analysis and should be granted at least one well designed human trial 
(84). 
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Part of the research in Chapter 3 has been published in the International Journal of 
Food Microbiology (Addendum). Chapters 3, 4 and 5 are written according to the 
style of Applied and Environmental Microbiology. 
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Chapter 3 
 
 
 
Expression of mucus adhesion genes of Lactobacillus plantarum 423 
and Lactobacillus acidophilus ATCC 4356 under digestive stress 
conditions in vitro, as monitored with real time PCR 
 
Abstract 
Expression of the mucus adhesion genes mub and mapA, adhesion-like factor 
EF-Tu and bacteriocin gene plaA by Lactobacillus plantarum 423, and expression 
of mub, slp and EF-Tu by Lactobacillus acidophilus ATCC 4356, grown in the 
presence of mucin, bile, pancreatin and at low pH, was studied by real time PCR. 
mub, mapA and EF-Tu of strain 423 were up-regulated in the presence of mucus, 
proportional to increasing concentrations. Expression of mapA by strain 423 was 
up-regulated in the presence of 0.3% (w/v) bile and 0.3% (w/v) pancreatin at pH 
6.5. Similar results were recorded in the presence of 1.0% (w/v) bile and 1.0% 
(w/v) pancreatin at pH 6.5. Expression of mub, on the other hand, was down-
regulated in the presence of bile and pancreatin at pH 6.5, whilst the expression 
of EF-Tu and plaA remained unchanged under these conditions at pH 6.5. 
Expression of mapA and mub by strain 423 remained unchanged at pH 4.0, whilst 
expression of EF-Tu and plaA were up-regulated. Expression of mapA was down-
regulated in the presence of 0.1% (w/v) cysteine, suggesting that the gene is 
regulated by a mechanism of transcription attenuation that involves cysteine. In 
the case of strain ATCC 4356, none of the genes were up-regulated under 
increasing concentrations of mucin, whilst slp and EF-Tu were up-regulated 
under normal and stress conditions. Expression of mub was not affected under 
normal conditions but was down-regulated under stress conditions. 
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Introduction 
Lactic acid bacteria are regarded probiotic if they successfully compete with 
intestinal pathogens and restore the normal microbiota. One of the first biological 
barriers encountered by probiotic bacteria is low pH in the stomach. Those cells that 
survive such extreme conditions are exposed to further stress in the small intestine, 
inflicted by bile salts and pancreatic juice (7). 
Probiotic bacteria compete with intestinal microorganisms for adhesion to mucus 
and epithelial cells by competition for receptor sites. The production of antimicrobial 
agents such as organic acids, diacetyl, hydrogen peroxide and bacteriocins aid in the 
survivability of these microorganism in the digestive tract (19, 20, 29). A few strains 
produce specific adhesion proteins. The best studied examples are the mucus binding 
protein (Mub) and the mucus adhesion promoting protein (MapA) produced by 
Lactobacillus reuteri (28, 31). Five proteins homologous to the Mub protein of L. 
reuteri 104R have been described for Lactobacillus acidophilus NCFM (3). Mub 
homologues have also been reported for Lactobacillus gasseri, Lactobacillus 
johnsonii and Lactobacillus plantarum (3). 
An adhesion-like protein, classified as elongation factor Tu (EF-Tu), was isolated 
from Lactobacillus johnsonii NCC 533 (La1) (15). EF-Tu facilitates the transfer of 
aminoacyl-tRNA to the A-site of ribosomes during protein synthesis (12). However, 
the EF-Tu protein also binds to mucin and mediates the colonisation of strain NCC 
533 to human intestinal cells and mucus (15). The mechanism by which EF-Tu 
interacts with mucin is not well understood. An EF-Tu protein isolated from L. 
plantarum shared 84% homology with the EF-Tu protein of L. johnsonii NCC 533 
(15). 
Surface layers (S-layers) are crystalline structures composed of protein or 
glycoprotein subunits with molecular masses ranging from 25 to 71 kDa for 
Lactobacillus spp. (30). These S-layer proteins (Slp) consist of a high content of 
hydrophobic amino acid residues with values ranging from 31.9% to 38.7% (32). A 
general functional property for all S-layer proteins has not been determined. Several 
functions have been postulated, such as protection against harsh environmental 
conditions (21), phage receptor sites (16) and adhesion to intestinal cells (8). The Slp 
of L. acidophilus ATCC 4356 has been characterized and expressed in Escherichia 
coli (6). 
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Lactobacillus plantarum and Lactobacillus acidophilus are common inhabitants of 
the human gastrointestinal tract and are also incorporated as starter cultures in the 
production of several types of fermented foods (2, 13). Strain 423, isolated from 
sorghum beer produces a bacteriocin, plantaricin 423, resistant to treatment at 80°C 
and incubation in MRS broth at pH 1.0 to 10.0 (34). The genes encoding plantaricin, a 
typical class IIa peptide, have been sequenced (35). The peptide is active against food-
borne pathogens, including Bacillus cereus, Clostridium sporogenes, Enterococcus 
faecalis, Listeria spp. and Staphylococcus spp. (34).  
Previous studies on adhesion of probiotic bacteria have focussed mainly on 
phenotypic aspects, such as in vitro models with mucus or epithelial cells (4, 24, 33). 
No previous investigation has attempted to explore the expression of adhesion genes 
when cells are exposed to stress conditions simulating the gastrointestinal tract. The 
present study investigated the expression of mub, mapA, EF-Tu and the structural gene 
of plantaricin 423 (plaA) of L. plantarum 423, as well as the expression of mub, slp 
and EF-Tu of L. acidophilus ATCC 4356 when cultured in the presence of bile salts, 
pancreatic juice and low pH. Up-regulation of the genes when strains were cultured 
under varying conditions of mucin, was also examined. Gene expression was 
monitored with real time PCR. 
 
Materials and Methods 
Bacterial strains and culture conditions 
Lactobacillus plantarum 423 and Lactobacillus acidophilus ATCC 4356 were 
cultured in De Man Rogosa Sharpe (MRS) broth (Biolab, Biolab Diagnostics, 
Midrand, South Africa) at 37°C, without aeration. Gene expression studies were 
conducted in MRS broth (Biolab) supplemented with porcine mucin (Sigma, 
Mannheim, Germany), bile and pancreatin, to simulate normal and stressful gut 
conditions (Table 1). The effect of cysteine on the expression of mapA was examined 
in MRS broth (Biolab), supplemented with 1.0 g/l L-cysteine HCl. 
Acidocin production 
L. acidophilus ATCC 4356 was cultured in MRS broth (Biolab) for 18 h (OD600 = 
approximately 4.0). The culture was centrifuged at 10 000 × g for 10 min and the 
supernatant collected. The pH of the cell-free culture supernatant was adjusted to 5.5 
with 0.5 M HCl and then boiled for 10 min. Production of the bacteriocin, acidocin 
was tested against Lactobacillus sakei LMG 13558 for zones of inhibition on MRS 
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agar plates, as described by Ivanova et al. (17). The bacteriocin was treated with 
Proteinase K, trypsin, α-amylase and lipase and again tested for activity. 
Primer design and PCR 
Primers used in this study are listed in Table 2. Primers for the amplification of 
plaA were designed from the structural gene encoding plantaricin 423 (35). All other 
primer sequences for L. plantarum 423 were designed from the genome sequence 
published for L. plantarum WCFS1 (accession number NC 004567). The mub, EF-Tu 
and GDPH (glyceraldehyde 3-phosphate dehydrogenase gene) primer sequences for L. 
acidophilus ATCC 4356 were designed from the genome sequence published for L. 
acidophilus NCFM (accession number NC 006814). Primers for the Slp of strain 
ATCC 4356 have been designed from the published sequence (6). Primers were 
designed with the Primer Designer Program, version 1.01 (Scientific and Educational 
Software). The GC content of the primers ranged between 30 and 40% and the Tm 
from 55 to 65°C. Primer sets were designed to produce an amplicon of approximately 
150bp. Primer dimer formation was checked by agarose gel electrophoresis (2% 
agarose) and melting curve analysis. A standard curve consisting of the Log template 
concentration plotted against the Ct value (crossing points of different standard 
dilutions), was constructed for each primer set. Efficiencies were calculated by E = 
10(-1/S) – 1, where S = slope of the standard curve. 
RNA isolation and cDNA synthesis 
Total RNA was isolated from 500 µl of 18 h cultures (OD600 = approximately 4.0), 
using the RNeasy Mini Kit (Qiagen, Valencia, California, USA). RNA was stabilised 
in two volumes of RNAprotect bacteria reagent (Qiagen), prior to isolation. Cells were 
harvested (5000 × g, 10 min, 4°C) and lysed by incubation with lysozyme (6 µl of 50 
mg/ml lysozyme per 100 µl TE buffer) for 20 min at 37°C. RNA was resuspended in 
40 µl DEPC-treated distilled water. Residual DNA was removed with turbo DNase 
treatment, according to instructions from the supplier (Ambion, USA). RNA (0.2 µg) 
was transcribed into cDNA using the Transcriptor First Strand cDNA Synthesis Kit 
(Roche Diagnostics, Mannheim, Germany) and gene specific primers. The reaction 
occurred for 30 min at 55°C. 
Real time PCR 
Standard curves were used to determine expression efficiencies between the target 
and reference genes. The standard curves and their efficiencies were calculated similar 
to the primer efficiencies. Target concentrations were adjusted by normalising against 
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the glyceraldehyde 3-phosphate dehydrogenase gene, which served as the endogenous 
reference, by dividing the average concentration of target DNA by the average 
concentration of reference DNA. The relative gene expression levels were compared 
by dividing the normalised target concentration by the control sample (cells grown in 
MRS, medium 1), and vice versa. 
Real time PCR reactions were performed in a LightCycler instrument (Roche), 
with Relative Quantification Software (version 5.32; Roche) and SYBR Green 
technology (Sigma). Each 20 µl reaction mixture consisted of 10 µl SYBR Green 
Supermix, 1 µl of each primer at 5 µM, 7 µl nuclease-free water and 1 µl diluted 
cDNA. Five dilutions of cDNA were prepared. A negative control (no template) was 
included in each run. Synthesis of cDNA and real time PCR was performed in 
triplicate for each gene. The PCR conditions were as follows: Initial denaturation at 
95°C for 15 min, followed by 40 cycles of amplification at 50°C for 10 sec and 72°C 
for 15 sec. At the end of each run a melting curve was performed from 95°C to 45°C 
(0.2°C.s-1). 
 
Results 
All primers and standard curves displayed an efficiency of above 80% (Figs. 1, 2, 
3 and 4). A single product-specific melting curve was obtained for each primer set, 
indicating that primers were designed with optimal efficiency and were effective in 
targeting and amplifying only the genes of interest. Both strains survived exposure to 
0.5 M HCl at pH 2.0 which reveals that the strains are capable of surviving gastric 
transit. L. acidophilus 4356 produces the bacteriocin acidocin that is active against L. 
sakei. The bacteriocin was completely inactivated by treatment with Proteinase K, 
trypsin and α-amylase, indicating its glyco-proteinaceous nature. 
 
Expression of mub 
Genes are considered to be up-or down-regulated if their relative expression levels 
are at least two-fold higher or lower respectively, when compared to the control 
sample or the calibrator (9). The mub gene of L. plantarum 423 was expressed 80-fold 
more when grown in the presence of 0.01% (w/v) mucin and 144-fold more when 
grown in the presence of 0.05% (w/v) mucin. However, the gene was suppressed 
when cells were grown under normal gut conditions, i.e. 0.3% (w/v) bile, 0.3% (w/v) 
pancreatin, pH 6.5, and conditions simulating stress (1%, w/v, bile; 1%, w/v, 
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pancreatin; pH 6.5). Expression was down-regulated 7-fold under normal intestinal 
conditions and 34-fold under stressful conditions (Table 3). Expression of mub 
remained unchanged at pH 4.0 (results not shown). 
In the case of L. acidophilus ATCC 4356, the mub gene was not up-regulated in 
the presence of 0.01% or 0.05% (w/v) mucin. Expression of the gene did not seem to 
be altered under normal gut conditions (0.3%, w/v, bile; 0.3%, w/v, pancreatin; pH 
6.5). However, the gene was down-regulated 18 fold when cells were cultured under 
stressful gut conditions (Table 4). 
Expression of EF-Tu 
The EF-Tu gene of L. plantarum 423 was significantly induced when cells were 
grown in medium supplemented with mucin. The gene was expressed 33-fold higher 
in the presence of 0.01% (w/v) mucin and 105-fold higher in the presence of 0.05% 
(w/v) mucin (Table 3). Expression of the gene was not affected by varying 
concentrations of bile and pancreatin. Cells grown at pH 4.0 expressed EF-Tu 6-fold 
higher compared to the control sample (cells grown in MRS) (results not shown). 
The EF-Tu gene of L. acidophilus ATCC 4356 was only up-regulated under 
normal (44-fold) and stressful (14-fold) gut conditions (Table 4). No change in 
expression was monitored in the presence of mucus. 
Expression of mapA 
The mapA gene of strain 423 was up-regulated when cells were incubated in the 
presence of mucin. Expression was 6 and 8-fold higher in the presence of 0.01% (w/v) 
mucin and 0.05% (w/v) mucin, respectively. The mapA gene was significantly up-
regulated under normal and stressful conditions. Under normal conditions, MapA was 
expressed 25-fold higher when compared to the control sample (Table 3). At pH 4.0, 
the gene was up-regulated twice as much as the control (results not shown). In the 
presence of 0.1% (w/v) cysteine, mapA was considerably down-regulated (17-fold) 
(results not shown). 
Expression of plaA 
Expression of plaA was not influenced by changes in bile, pancreatin and pH 
(Table 3). 
Expression of slp 
The Slp of L. acidophilus ATCC 4356 does not seem to be stimulated by mucin as 
no up-regulation of the gene was monitored when the strain was cultured under 
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varying concentrations of mucin (Table 4). However, the gene was induced 33-fold 
under normal in vitro conditions and 4-fold under stressful conditions. 
 
Discussion 
Colonisation of the intestinal tract is considered a prerequisite for probiotic 
bacteria (26). Most studies report on the adhesion of probiotic bacteria to intestinal 
cell lines (1, 10, 14). Although this may be a useful indication of adhesion, it is not 
always a reflection of the ability of the bacteria to adhere to mucus covering the 
intestinal cells (25). The mucus layer serves a dual function. It may prevent the 
adhesion of pathogenic bacteria, thereby protecting the intestinal cells, but also serves 
as a nutrient source and matrix for colonisation of probiotic bacteria (23). Adhesion to 
mucosa is important for proliferation of probiotic cells, especially in the small 
intestine with high flow rates (36). Furthermore, adhesion stimulates the immune 
system (25). In at least one study (11), it has been claimed that damaged gastric 
mucosal cells are repaired by the adherence of probiotic lactobacilli. 
From first studies, it was concluded that the EF-Tu molecule is restricted to the 
cytoplasm of prokaryotes. However, later studies have shown that this molecule is 
also associated with the membrane of E. coli (18) and the periplasm of Neisseria 
gonorrhoeae (27). In lactobacilli, EF-Tu may function as an “envelope associated 
protein,” which may be released from the cell when the organism experiences osmotic 
shock (22). Granato et al. demonstrated the presence of EF-Tu on the outer surface of 
5 Lactobacillus and 2 Bifidobacterium strains. The concentration of EF-Tu on the 
surface of the strains differed, suggesting possible differences in expression (15). In 
this study, up-regulation of EF-Tu of L. plantarum 423 in the presence of mucus 
suggests that the EF-Tu molecule may also play a role in adhesion. This correlates 
well with work done by Granato et al. (15). Furthermore, expression of the gene was 
not affected by digestive stress conditions in vitro and may thus contribute to the 
colonisation of the strain in the digestive tract. Conversely, in L. acidophilus ATCC 
4356, EF-Tu was not up-regulated in the presence of porcine mucus. However, EF-Tu 
was up-regulated under normal and stressful conditions. These results suggest that the 
EF-Tu molecule may only mediate adhesion and facilitate colonisation in certain 
lactobacilli strains. 
None of the genes tested for L. acidophilus 4356 were up-regulated in the presence 
of porcine mucin. Induction of slp only occurred under normal digestive conditions. 
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This suggests that one of the main functional roles of Slp in L. acidophilus may not be 
associated with the adherence of the strain to mucus. With regards to strain 423, all 
the mucus adhesion genes were significantly up-regulated in the presence of mucus 
and expression levels increased with increasing concentrations of mucus. Under 
normal physiological concentrations of bile and pancreatin, expression of the mub 
gene was affected, the mapA gene was over-expressed and the EF-Tu gene remained 
stable. Similar results were obtained when L. plantarum 423 was exposed to digestive 
stress. This suggests that, whilst the expression of certain genes, whose products 
interact with mucus, may be affected by bile and pancreatin, others genes are switched 
on, enabling the strain to adapt to physiological conditions and adhere to the 
gastrointestinal tract. 
The pH of the gut lumen is 6.5, but it has been postulated that it becomes slightly 
more acidic closer to the mucus-covered surface, owing to the sulfated content and 
sialic residues of mucin (5, 15). Hence, expression of the adhesion genes of strain 423 
were also investigated at pH 4.0. Variations in pH did not influence the expression of 
the genes negatively, as none were down-regulated at lower pH (results not shown). 
Regulation of mapA was also investigated. Expression of mapA from L. reuteri 
104R is regulated by a mechanism of transcription attenuation, involving cysteine 
(31). Our studies indicate that mapA of L. plantarum 423 is down-regulated in the 
presence of 0.1% (w/v) cysteine. Hence, cysteine participates as an effector molecule 
and represses transcription of mapA in the presence of excess cysteine. 
 
Conclusions 
Lactobacillus plantarum 423 complies with most of the major criteria required to 
be classified as a probiotic. Expression of plaA was not affected by digestive stress 
conditions in vitro and strain 423 survived exposure to HCl at pH 2.0. Expression of 
adhesion genes by strain 423 was positively regulated in the presence of mucus. 
Variations in pH did not affect expression of the adhesion genes, whilst bile and 
pancreatin only affected the mub gene. L. plantarum 423 is capable of adapting to 
conditions in a normal healthy intestine and has the necessary genetic characteristics 
required for an effective probiotic. 
Lactobacillus acidophilus ATCC 4356 survived exposure to HCl at pH 2.0. The 
organism may not display strong adhesive properties as none of the adhesion genes 
were up-regulated in the presence of mucus. However, up-regulation of slp and EF-Tu 
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in the presence of bile and pancreatin indicated that the strain has the ability to adapt 
to physiological conditions. Other adhesion genes may be involved in effective 
colonisation of strain ATCC 4356 to the gastrointestinal tract. Results of the present 
investigation support the theory of receptor mediated adhesion as similar genes in 
different organisms react differently to surface components such as mucus. 
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Table 1: Modification of MRS broth (Biolab) to simulate gastric conditions. 
Mediuma Mucinb % Bile % (w/v) Pancreatin % pHc 
1 0 0 0 7 
2 0.01  0 0 7 
3 0.05  0 0 7 
4 0.01  0.3  0.3  6.5 
5 0.01  1  1  6.5 
6 0.01  0.3  0.3  4 
a Medium 4 simulates normal gut conditions and media 5 and 6 stress conditions. 
b Porcine mucus (Sigma, Manheim, Germany) 
c Adjusted with 0.5 M HCl 
 
 
Table 2: Primers used in the study 
Primer set Sequence 5’to 3’ Size of amplicon (bp) 
 
Bac 423F RT 
Bac 423R RT 
 
Mub 423F RT 
Mub 423R RT 
 
Map 423F RT 
Map 423R RT 
 
EFTu 423F RT 
EFTu 423R RT 
 
GDPH 423F RT 
GDPH 423R RT 
 
Mub 4356F RT 
Mub 4356R RT 
 
Slp 4356F RT 
Slp 4356R RT 
 
EFTu 4356F RT 
EFTu 423R RT 
 
GDPH 4356F RT 
GDPH 4356R RT 
 
 
GACATTTACATTGAGTAGGAACTAG 
GTAACCCCATTACCATAGTATTTAC 
 
GTAGTTACTCAGTGACGATCAATG 
TAATTGTAAAGGTATAATCGGAGG 
 
TGGATTCTGCTTGAGGTAAG 
GACTAGTAATAACGCGACCG 
 
TTCTGGTCGTATCGATCGTG 
CCACGTAATAACGCACCAAC 
 
ACTGAATTAGTTGCTATCTTAGAC 
GAAAGTAGTACCGATAACATCAGA 
 
GTAATCGTGTTCTACATATACATAG 
GGTTATAAAGTTAACAGCATTGTTC 
 
GCACAACGCATACTACTACG 
CTTGTCAACAGCCTTACCGT 
 
GGTGCTATCTTAGTTGTTGC 
CAACCAAGTCGATCAATTCT 
 
CTATCGTTTACTCAGTAAACCAAGA 
CGTGGATAGTAGTCATAGTACCAAC 
 
 
147 
 
 
150 
 
 
156 
 
 
161 
 
 
140 
 
 
152 
 
 
150 
 
 
150 
 
 
149 
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Table 3: Expression of mub, mapA, EF-Tu and plaA of L. plantarum 423 
Genes Medium Av. Ct Quant.* GDPH Av. Ct Quant. Normalised Set to Control 
1 24.98 38.9 21.64 57.5 0.68 1
2 24.5 53.7 27.93 1 53.7 80 
3 23.61 97.7 27.91 1 97.7 144 
4 25.28 31.6 19.19 316 0.1 7 
m
ub
 
5 27.86 5.4 18.88 316 0.02 34 
1 26.4 41.7 21.62 398.1 0.1 1
2 25.78 60.3 23.64 104.7 0.6 6 
3 25.73 61.7 24.16 74.1 0.8 8 
4 26.95 30.2 26.94 12.02 2.5 25 
m
ap
A 
5 27.1 27.5 25.91 23.4 1.2 12 
1 20.3 66.1 22.76 21.9 3 1
2 19.36 117.5 28.06 1.2 97.9 33 
3 17.63 346.7 27.94 1.1 315.2 105 
4 17.85 302 18.64 269 1.1 2.7 
EF
-T
u 
5 17.44 398 18.48 295 1.3 2.3 
1 20.62 91.2 23.97 15.5 5.8 1
2 20.21 114.8 23.89 16.2 7.1 1.2 
3 20.19 117.5 24.42 11.5 10.2 1.8 
4 24.3 10 27.45 1.4 7.1 1.2 
pl
aA
 
5 22.36 32.4 26.58 2.6 12.5 2.2 
 
*Calculation of the quantity of each gene was determined from the standard curves 
constructed for the specific genes. 
 
Table 4: Expression of mub, slp and EF-Tu of L. acidophilus ATCC 4356 
Genes Medium Av. Ct Quant.* GDPH Av. Ct Quant. Normalised Set to Control 
1 30.74 6.17 30.88 2.5 2.5 1
4 32.26 2.4 31.99 1.3 1.9 1.3 
m
ub
 
5 31.5 3.8 27.14 27.5 0.14 18 
1 19.76 2.1 30.88 2.63 0.8 1
4 15.25 34.67 31.99 1.3 26.7 33 
slp
 
5 15.9 23 29.3 7.2 3.2 4 
1 24.63 1.7 26.98 12.9 0.13 1
4 21.13 14.13 29.59 2.5 5.7 44 
EF
-T
u 
5 18.42 72.4 25.16 39.8 1.82 14 
 
*Calculation of the quantity of each gene was determined from the standard curves 
constructed for the specific genes. 
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FIG. 1. Standard curves of the different genes for L. plantarum 423. mub (y = -
3.356x + 30.302), EF-Tu (y = -3.664x + 26.952), plaA (y = -3.88x + 28.218), mapA (y 
= -3.876x + 32.68).  
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FIG. 2. Standard curves of glyceraldehyde 3-phosphate dehydrogenase for the 
different genes of L. plantarum 423. EF-Tu (y = -3.766x + 27.796), mub (y = -3.58x + 
27.958), mapA (y = -3.504x + 30.72), plaA (y = -3.346x + 27.952). 
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FIG. 3. Standard curves of the different genes for L. acidophilus 4356. mub (y = -
3.75x + 33.688), slp (y = -3.684x + 20.926), EF-Tu (y = -3.81x + 25.5). 
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FIG. 4. Standard curves of glyceraldehyde 3-phosphate dehydrogenase for the 
different genes of L. acidophilus 4356. mub (y = -3.654x + 32.338), slp (y = -3.584x + 
32.384), EF-Tu (y = -3.706x + 31.088). 
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Chapter 4 
 
 
 
Evaluation of the adhesive properties of the probiotics Lactobacillus 
plantarum 423 and Enterococcus mundtii ST4SA to rat intestinal 
tissue 
 
Abstract 
The adhesive properties of probiotic strains Lactobacillus plantarum 423 and 
Enterococcus mundtii ST4SA were evaluated in male Wistar rat models using 
fluorescent in situ hybridization (FISH) incorporating fluorescently labeled 
strain-specific oligonucleotide probes. Tissue samples collected from the 
intestinal tract of rats were subjected to real time PCR (RT-PCR) to quantify 
strains in different sections of the gastrointestinal tract. Results obtained with 
FISH indicated that L. plantarum 423 adhered strongly to the surfaces of the 
ileum and the cecum, but did not colonise the colon. These results were 
confirmed with RT-PCR. E. mundtii ST4SA adsorbed to the epithelial cells of the 
cecum and colon, but penetrated the cells. No changes in tissue morphology or 
other toxic defects were observed when tissue samples were stained with 
haemotoxylin eosin, suggesting that strains 423 and ST4SA are non-
inflammatory and non-toxic. 16S rDNA PCR and denaturing gradient gel 
electrophoresis (DGGE) was conducted to evaluate the effect of strains 423 and 
ST4SA to the natural microflora of rats. Data indicated that the lactic acid 
bacteria remained unchanged, whereas the Enterobacteriaceae population 
showed a clear decline. Strains 423 and ST4SA agglutinated yeast cells when 
tested in vitro, indicating the possible presence of mannose receptors on their cell 
surfaces. Type 1 fimbriated strains of E. coli use the same receptors for binding 
to epithelial cells. It is thus possible that strains 423 and ST4SA compete against 
certain E. coli and other enterobacteriacea for colonisation. 
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Introduction 
The adhesion of probiotic bacteria to intestinal mucosa facilitates a number of 
health benefits to the host. These include exclusion of pathogens, restoration of natural 
microflora after antibiotic treatment, reduction in carcinogens, lowering of blood 
pressure (15), stimulation of the immune system (26) and a decrease in cholesterol 
levels (7). An effective probiotic is often evaluated by its ability to colonise the 
intestinal tract or its ability to compete against pathogens for adhesion sites (14). 
Exclusion of pathogens by probiotic bacteria provides a healthy gut with balanced 
microflora (30). 
The mucosal layer in the intestinal tract plays an essential role in maintaining a 
barrier against the interaction of toxic substances and pathogenic bacteria from the 
lumen content. Previous reports have indicated that pathogenic bacteria like 
Salmonella typhi (18) and Escherichia coli (33) may damage the intestinal barrier and 
increase permeability at the mucosal surface. Other studies have shown that the 
adhesion of lactobacilli to the mucosal surface prevents the translocation of pathogens 
(1) and thereby inhibits intestinal inflammation (21). Lactic acid bacteria and 
pathogenic bacteria compete for receptor sites at the mucosal surface. One of these 
receptors includes the mannose receptor and mannose specific adherence has been 
demonstrated in many L. plantarum strains (28). Type 1 fimbriated E.coli also adhere 
to mannose residues on the intestinal epithelial cells of humans and rats (2, 13). The 
adhesion of probiotic lactic acid bacteria, such as L. plantarum, to host intestinal 
tissue may thus directly hinder the colonisation of pathogenic E. coli strains. 
Cell counts from fecal samples illustrate the survival rate of administered 
probiotics (19). However, this does not provide an indication of the adherence of cells 
to the intestinal tissue or the number of cells that remain colonised. Fluorescent in situ 
hybridization (FISH) has been used to detect lactobacilli in pig mucus and epithelial 
tissue (22). The technique has also been successfully used to detect and quantify 
predominant groups of anaerobic bacteria in human fecal samples (10). 
Lactic acid bacteria are used as starter cultures in a variety of fermented products 
and are generally regarded as safe. These organisms are common inhabitants of a 
number of environmental niches, including the human and animal gastro-intestinal 
tract. L. plantarum 423 and Enterococcus mundtii ST4SA were isolated from sorghum 
beer and soybean flour, respectively (17, 35). Both strains produce bacteriocins that 
are resistant to treatment at 80ºC and incubation in MRS broth at pH 1.0 to 10.0. The 
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bacteriocins are also active against a number of food-borne pathogens, including 
Bacillus cereus, Clostridium sporogenes, Enterococcus faecalis and Listeria 
monocytogenes (17, 35). 
In this study, we report on the adhesion of two probiotic strains, L. plantarum 423 
and E. mundtii ST4SA, to rat intestinal tissue. FISH with strain-specific probes were 
used to detect strains 423 and ST4SA. Real time PCR with strain-specific primers was 
used to quantify strains in different sections of the gastrointestinal tract. 16S rDNA 
PCR and DGGE was used to determine the effect of the probiotics on 
enterobacteriacea and lactic acid bacteria, naturally present in the intestinal tract of the 
rats. 
 
Materials and Methods 
Bacterial strains and dosage preparation  
Lactobacillus plantarum 423, Enterococcus mundtii ST4SA and L. plantarum 
WCFS1 were cultured in De Man Rogosa Sharpe (MRS) broth (Biolab, Biolab 
Diagnostics, Midrand, South Africa) at 37°C to OD600nm = 4.0. Ten ml cultures of L. 
plantarum 423 and E. mundtii ST4SA were harvested (10000 × g, 10 min at 4ºC), 
washed twice in sterile physiological water, resuspended in 10% sterile skim milk and 
lyophilised in separate vials. One vial lyophilised cells of each strain was resuspended 
in 1 ml sterile physiological water, serially diluted and plated onto MRS (Biolab) agar 
to determine the number of viable cells. Lyophilised cells in the other vials were 
suspended in a predetermined volume of sterile physiological solution to yield 1 
×108cfu per 200 µl. 
Treatment of animals and tissue collection  
Approval to work with Wistar rats was obtained from the Ethics Committee of the 
University of Stellenbosch (ethics reference number: 2005B02003). Four-week-old 
male Wistar rats were divided into four groups (A, B, C, D) with six rats per group. 
The rats were contained in a controlled environment (23 ± 2°C) and had free access to 
feed and drinking water. Probiotics were administered via intragastric gavage. Group 
A received 200 µl L.  plantarum 423, group B 200 µl E. mundtii ST4SA and group C a 
combination of the two strains (100 µl each). Group D served as the control and 
received 200 µl sterile physiological water. The rats were dosed once a day for 14 
days. Changes in body weight were monitored every alternate day. At the end of the 
14 day trial, the rats were anaesthetised with an overdose (1 ml) of sodium 
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pentobarbitone (200 mg/ml). Blood was drawn via cardiac puncture of the right 
ventricle. The rats were dissected and samples of the duodenum, jejunum, ileum, 
cecum and colon were removed aseptically. Approximately 2 cm sections were placed 
in cassettes and immersed in 4% paraformaldehyde in 0.1 M PBS (0.2 M NaH2PO4, 
0.2 M Na2HPO4, pH 7.2). The remaining tissue samples were homogenised in 0.1 M 
PBS pH7.2 (0.3 g/ml) and stored at -20°C. 
Construction of strain-specific probes and FISH 
Primers Bac423 and MundST4SA were used to amplify the structural genes 
encoding bacteriocin 423 and peptide ST4SA, respectively (Table 1). Primers were 
designed with the Primer Designer Program, version 1.01 (Scientific and Educational 
Software) to yield a GC-content between 35 and 45%. PCR amplicons were labelled 
via the universal labelling system of the ULYSIS nucleic acid labelling kits 
(Molecular ProbesTm, Invitrogen Corporation, Carlsbad, California, USA). The Alexa 
Fluor 568 dye (Invitrogen) with a maximum absorbance at 576nm and emission at 600 
nm was used.  
Excised tissue fixed in 4% (v/v) paraformaldehyde (pH 7.2) for a minimum of 24 
h were dehydrated in a series of 70%, 90%, 95 and 98% (v/v) ethanol for 12.5 h, 
followed by 3.5 h of clearing in xylol and 4 h of impregnation in paraffin wax 
(Histosec). The tissues were sectioned with a R Jung microtome (Heidelberg, 
Germany) in 5 µm increments and placed on Poly-L-Lysine coated microscope slides 
(Lasec, Johannesburg, South Africa). Tissue sections were then deparaffinized and 
dehydrated by incubation in xylene for 5 min, followed by submersion in 98% (v/v) 
ethanol for 3 min and then in 95% (v/v) ethanol for 3 min. This was followed by a 3 
min submersion in 80% and 50% ethanol, respectively. The slides with sections were 
rinsed in sterile distilled water and submerged for 20 min in 0.1% (w/v) trypsin in 
PBS. Incubation was at 37°C. Slides were rinsed with sterile distilled water and dried 
for 20 min at 46ºC (31). Slides were treated with 20 µl lysozyme (20 mg/ml) for 20 
min at room temperature, rinsed with sterile distilled water and air dried. Slides were 
then covered with 50 µl hybridization buffer (5 mol/L NaCl; 1 mol/L Tris.Cl pH 8.0; 
0.01%, w/v, SDS and 25%, v/v, formamide) and 5 µl of the strain-specific probe (50 
ng/µl). Hybridisation was for 2.5 h at 46ºC in a moist chamber. The slides were 
submerged in 50 ml wash buffer (5 mol/L NaCl; 1 mol/L Tris.Cl pH 8.0; 0.01%, w/v, 
SDS and 0.5 mol/L EDTA, pH8.0) for 10 min at 48ºC (5). Slides were given a final 
rinse with sterile distilled water, air dried in the dark and stored at -20ºC, covered with 
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fluorescent mounting medium (Dako Cytomation) to prevent photobleaching. Tissue 
sections from group D rats served as the controls. 
The tissue sections were observed through an Olympus cellR system attached to an 
IX-81 inverted fluorescence microscope, equipped with a 10× lens (UPlan FLN, 
Olympus), a 20× lens (LucPlan FLN, Olympus), a 40× lens (LucPlan FLN, Olympus) 
and a 60× lens (PlanApoN 1.42 N.A. oil immersion) (Olympus Biosystems GMBH, 
Germany). Samples were visualized with 400x and 600x magnification. The sample 
was excited through an excitation filter for Texas Red (572nm). CellR imaging 
software was used for the image acquisition and analysis. 
Haemotoxylin and eosin staining (H&E) 
Tissue sections were prepared for haemotoxylin-eosin (H&E) staining similar to 
the method used to prepare slides for FISH. All samples were analysed by PathCare 
veterinary pathologists (Cape Town, South Africa). 
Quantification of strains with real time PCR 
Homogenised tissue (300 µl) were inoculated into 100 ml MRS (Biolab) and 
incubated for 18 h at 37ºC, without aeration. Plasmid isolation was performed using 
the QIAprep Spin Miniprep Kit (Qiagen, Valencia, California, USA), according to 
the manufacturer’s instructions and eluted in 100 µl sterile milliQ water.  
Primers used for the amplification of the genes encoding bacteriocin 423 and 
antimicrobial peptide ST4SA, are listed in Table 1. Primer sets were designed to 
produce amplicons smaller than 150bp. Primer dimer formation was checked by 
agarose gel electrophoresis (2% w/v, agarose) and melting curve analysis.  
Standard curves were used for quantification and consisted of Log template 
concentration of DNA plotted against the Ct-value (crossing points of different 
standard dilutions). Efficiencies were calculated by E = 10(-1/S) – 1, where S = slope of 
the standard curve. Real time PCR reactions were performed in a LightCycler 
instrument (Roche, Mannheim, Germany), with Relative Quantification Software 
(version 5.32; Roche) and SYBR Green technology (Sigma, Missouri, USA). Each 20 
µl reaction mixture consisted of 10 µl SYBR Green Supermix (Sigma), 1 µl of each 
primer at 5 µM, 7 µl nuclease-free water and 1 µl diluted plasmid DNA. Five dilutions 
of plasmid DNA were prepared. A negative control with sterile Milli Q water, was 
included in each run. Isolation of plasmid plasmid DNA and RT-PCR was performed 
in duplicate for each of the two strains in each tissue sample. PCR conditions were as 
follows: initial denaturation at 95°C for 15 min, followed by 40 cycles of 
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amplification at 50°C for 10 sec and 72°C for 15 sec. At the end of each run a melting 
curve was performed from 95°C to 45°C (0.2°C.s-1). 
16SrDNA PCR and denaturing gradient gel electrophoresis (DGGE) 
Homogenized tissue samples from different sections of the intestinal tract (300 µl) 
were inoculated into 10 ml MRS broth (Biolab) and 10 ml MacConkey broth (Biolab) 
at 37°C to OD600nm = 1.8, for the isolation of lactic acid bacteria (9) and 
Enterobacteriaceae (23), respectively. DNA isolated from homogenised tissue 
samples of group D rats inoculated into 10 ml MRS broth (Biolab) and 10ml 
MacConkey broth (Biolab), served as the controls. 16S rDNA amplification was 
carried out in a Gene Amp® PCR 9700 system (Applied Biosystems, California, 
USA), with primers 341FGC (5’-CGCCCGCCGCGCGCGGCGGGCGGGGC 
GGGGGCACGGGGGGCCTACGGGAGGCAGCAG –3’) and 534R (5’- 
ATTACCGCGGCTGCTGG –3’), designed to target conserved 16S rDNA sequences 
(24). Primers were selected to produce 193bp PCR amplicons encompassing the V3 
region of the 16SrDNA gene. The forward primer was modified with a GC-clamp to 
impart melting stability to the DNA fragments for efficient DGGE analysis. The PCR 
mix included the following: 5 µl of 10 × buffer, 3 µl of 25 mM MgCl2, 5 µl of 5 µM 
341FGC, 5 µl of 5 µM 534R, 4 µl of 2.5 mM DNTP’s, 0.5 µl of Taq polymerase 
enzyme (Takara, Shiga, Japan) and 1 µl of genomic DNA (100 ng/µl). Each reaction 
was adjusted to a final volume of 50 µl with sterile milli Q water.  
DGGE was performed with a 10% (w/v) polyacrylamide gel (37.5:1, 
acrylamide:bisacrylamide) with a gradient ranging from 30% – 60%. Usually, 100% 
denaturant corresponds to 7 M urea and 40% (w/v) acrylamide. The 30% gradient 
contained 5 ml of 40% (w/v) polyacrylamide, 1 ml of 10 × TAE, 2.4 ml formamide, 
2.5 g urea and was adjusted to a final volume of 20 ml with distilled water. The 60% 
gradient contained 5 ml of 40% (w/v) polyacrylamide, 1 ml of 10 × TAE, 4.8 ml 
formamide, 5.0 g urea and was adjusted to a final volume of 20 ml with distilled 
water. Polymerisation was catalysed by 140 µl of 10% ammonium persulfate and 14 
µl of TEMED. Electrophoresis was at a constant 100V for 16 h at 60°C in the 
DCodeTM Universal Mutation Detection System (Bio-Rad, Laboratories, USA). 
Electrophoresis buffer consisted of 0.5 × TAE (20 mM Tris-acetate pH 7.4, 10 mM 
sodium acetate and 0.5 mM EDTA pH 7.4) (24, 25). 
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Agglutination of yeast cells 
L. plantarum 423, E. mundtii ST4SA and Lactobacillus plantarum WCFS1 were 
cultured in MRS broth (Biolab) at 37°C to OD600nm = 1.8 (1 × 106 CFU/ml). Cells were 
harvested, (10000 × g, 10 min at 4ºC), washed twice in sterile physiological water and 
resuspended in PBS (pH 7.2). Cells were then serially diluted with PBS (pH 7.2) in a 
96-well microtitre plate. An equal volume of PBS was added to the cells, followed by 
the addition of double the volume of 1% (w/v) commercially available bakers’ yeast 
(Saccharomyces cerevisiae). The plates were shaken on an orbital platform shaker for 
5 min and incubated for 16 h at 4ºC. Agglutination was observed by light microscopy 
under 400 × magnification. The agglutination titre was calculated according to the 
method described by Adlerberth et al. (3). L. plantarum WCFS1, treated the same 
way, was used as the positive control. 
 
Results 
FISH 
Fig. 1 illustrates FISH images composed of the fluorescent image, phase image 
(no fluorescence) and the overlayed image (fluorescent signal overlayed on the phase 
image), respectively. This was conducted to obtain a clear view of the fluorescent 
signals on each of the tissue samples. 
FISH depicted intense fluorescence of L. plantarum 423 along the epithelial lining 
of the cecum and villi of the small intestinal tissue of group A rats (Fig. 1A). Samples 
from all six rats investigated, displayed similar results (data not shown). The 
specificity of probe 423 was exemplified by FISH conducted on the intestinal tissue of 
the control rats. The fluorescent intensity in the control samples was not as intense or 
evident as the test samples (Fig. 1C). In the case of rats treated with E. mundtii 
ST4SA, clear intracellular fluorescence within the intestinal tissue was visible and 
much less along the epithelial lining (Fig. 1D). Tissue from all six rats were also 
investigated for strain ST4SA and similar results were observed in all samples (data 
not shown). 
Haematoxylin and Eosin Staining (H&E) 
H&E stains revealed no morphological changes or toxic defects induced to the rat 
tissue upon adhesion of L. plantarum 423 and E. mundtii ST4SA (Fig. 2). 
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Real time PCR 
The standard curves displayed an efficiency of above 90% (Fig. 3) and a single 
product specific melting curve was obtained for each primer set. This indicates that 
primers were designed with optimal efficiency and were effective in targeting the 
genes of interest.  
L. plantarum 423 colonised the ileum and cecum in highest numbers and did not 
adhere to the colon (Table 2). Results were recorded by the highest detection of the 
bacteriocin gene of strain 423 in the ileum and cecum tissue samples. Highest 
numbers of E. mundtii ST4SA was recorded in the cecum, followed by the colon. 
Little to no colonisation occurred in the small intestine, as expected with enterococci. 
16SrDNA PCR and denaturing gradient gel electrophoresis (DGGE) 
Colonisation of the strains to the intestinal tract significantly altered the 
enterobacterial composition of microbiota in the gut. This was evident by the adhesion 
of L. plantarum 423 to the ileum and cecum. The probiotic potential of strain 423 is 
further emanated by the displacement of Enterobacteriaceae in the colon, despite the 
non-adherence of strain 423 to this section of the digestive tract (Fig. 4A, blue arrow). 
The Enterobacteriaceae that were dislodged from the cecum by strains 423 and 
ST4SA is indicated in Fig. 4A and B, respectively (red brackets). Species that were 
detached from the colon by the probiotic action of strain ST4SA is indicated by the 
blue arrow (Fig. 4B). Results appear similar for both strains. The lactic acid bacteria 
population remained unaffected by the adhesion and colonisation of strains 423 and 
ST4SA (Figs. 4C and D). 
Agglutination of yeast cells 
Mannose-rich polysaccharides are a major component in the cell wall of 
Saccharomyces cerevisiae. Bacteria with mannose-specific adhesins agglutinate yeast 
in a mannose specific manner (3). L. plantarum 423 and E. mundtii ST4SA was 
evaluated for its ability to agglutinate yeast cells and display mannose adherence. 
Both strains exhibited strong agglutination of yeast cells. E. mundtii ST4SA displayed 
agglutination by at least four titre steps and L. plantarum 423 by three titre steps 
(results not shown). 
 
Discussion 
The ability of probiotic strains to adhere to gastrointestinal tissue is of extreme 
importance to prolong beneficial health effects in the host. Various techniques are 
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used to evaluate the adhesive properties of potential probiotic cells, including a 
number of in vitro studies with intestinal cell lines or mucus (12, 20, 27). The 
percentage survival of ingested cells has also been used as an indication of adhesion 
(11). However, not much information is available on the adhesion of probiotics to the 
intestinal tract in vivo. The present study successfully reports the use of FISH to 
evaluate the adhesion of two potential priobiotic strains to rat intestinal tissue.  
L. plantarum 423 displays strong adhesive properties, as indicated by the intense 
fluorescent signal along the epithelial lining of the rat intestinal tissue (Fig. 1A). Real 
time PCR indicated higher numbers of strain 423 in the ileum and cecum, compared to 
the colon. These results correlated well with FISH conducted on colonic tissue of 
group A rats, as no discernible fluorescent signal was observed on the epithelial lining 
(Fig. 1B), indicating no binding to the colon. These results suggest that 
gastrointestinal conditions and receptors in the small intestine and anterior colon 
favour the colonisation of strain 423. L. plantarum is a common inhabitant of a variety 
of food fermentation processes (8). Hence, its abundance in the cecum could be 
attributed to the high level of fermentation and digestion that occurs within this organ. 
The complete genome sequence of L. plantarum WCFS1 reveals the presence of a 
number of genes involved in the metabolism of various sugars, utilization of peptides 
and the formation of different amino acids (16). The small intestine is thus the ideal 
location for this organism, due to the abundance of micronutrients to stimulate the 
growth of L. plantarum. Adhesion of the organisms to this section of the intestinal 
tract will also assist the host in digestion and nutrient absorption. The mucus binding 
protein (Mub) isolated from Lactobacillus reuteri 1063 adhered to pig mucus within a 
pH range of 3-7.4 when studied in vitro (29). Mub homologues have also been 
described for L. plantarum 423 (4). Hence, the small intestine may provide optimal 
pH conditions for the binding of organisms that contain adhesion proteins such as 
Mub. This reflects the remarkable potential of L. plantarum as an efficient coloniser 
of the gastrointestinal tract. 
Accurate FISH analysis is dependent on a highly-specific probe as well as sample 
preparation. Significant research has been conducted on probe specificity (6, 10). 
However, not much has been done in evaluating and comparing various sample 
preparations. Previous reports have used mucus epithelial scrapings and homogenized 
samples to determine the presence of specific species (10, 22). However, this method 
does not provide an accurate representation of adhesion and proves ineffective for 
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determining the exact localization of the target organism. The present report makes 
use of homogenized tissue, mucus scrapings and formaldehyde fixed tissue as a 
comparative means of accurate detection. FISH conducted on homogenized samples 
and tissue scrapings proved vastly inaccurate as no significant differentiation in 
fluorescent intensity could be documented between the test and control samples. This 
was due to non-specific binding of the probe to cellular debris, particularly in the 
control samples. In addition, this method of analysis would have merely provided an 
indication of the presence of these strains in the various samples and is thus not an 
accurate indication of adhesion. This means of analysis proved crucial for evaluating 
the adhesion mechanism of E. mundtii ST4SA. FISH on formaldehyde fixed tissue of 
group B rats indicated translocation of strain ST4SA and intracellular activity. This 
data would not have been observed in the other sample preparations. Hence, sample 
preparation is imperative for high-quality FISH analysis, particularly when more than 
mere detection is of question. 
Translocation of enterococci across the intestinal barrier has been previously 
reported and was also shown to occur across vaginal epithelium (37). It has been 
suggested that the preferred site for translocation of E. faecalis in mice is the cecum 
and the colon (38). According to the translocation model, adherent luminal bacteria 
may be phagocytosed by intestinal epithelial cells or intraepithelial leukocytes (36). 
Spontaneous translocation of indigenous bacteria is thought to occur continuously in a 
healthy host (32). These bacteria may either exit through the apical side of the 
epithelial cells or migrate in phagocytes to mesenteric lymph nodes where they 
proliferate, spread to distant sites and cause infection (36). However, chances of this 
occurring is minimal, as these bacteria are generally killed en route (32). It has been 
suggested that this process may be beneficial to the host for stimulating protective 
immunity (32). Hence, the translocation of enterococci is not an uncommon 
phenomenon. However, it may only pose a serious threat if the enterococci are 
detected in sterile sites such as blood and if the organism elicits infection. In a 
separate study, the in vivo assessment on the safety of E. mundtii ST4SA in male 
Wistar rat models was evaluated. No deleterious effects such as weight loss or 
gastrointestinal disorders on the general health status of the rats were observed (Kim 
Ten Doeschate, personal communication). More importantly, no bacteremia has been 
detected in any of the rats and no adverse effects have been noted in haematological 
analysis. Macroscopic examination of the visceral organs and histological analysis of 
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tissues indicated no abnormalities (this study). The strain also exhibited no β-
glucuronidase activity in vitro and in vivo and was thus concluded to be non-toxic and 
safe for human consumption (34). 
Real time PCR denoted the presence of strain ST4SA in the cecum in highest 
numbers, followed by the colon. E. mundtii is a lactic acid enterobacterium. Hence, its 
presence in the cecum is expected due to the fermentation processes that occur within 
this organ and being an enterobacterium would elucidate its presence in the colon. 
Strains 423 and ST4SA were successful in modifying the gut microbiota in a 
positive manner. DGGE exhibited the absence of certain Enterobacteriaceae in the 
gut of rats fed with strains 423 and ST4SA, whilst the lactic acid bacterial content 
remain unchanged. Both strains also exhibited agglutination of yeast cells indicating 
the possible presence of mannose receptors. This is of paramount importance in the 
gut for excluding type 1 fimbriated pathogenic E. coli strains and other enterobacteria 
that display mannose adherence and might have contributed to the dislodging of 
possible E. coli strains in the gut. 
 
Conclusions 
L. plantarum 423 exhibits strong adhesive potential for a successful probiotic. The 
organism colonises the ileum and cecum of rats and positively influences the natural 
microflora by inhibiting enterobacteria whilst not affecting the lactic acid bacterial 
content. Strain 423 also displays the possible presence of mannose receptors. 
Histological analysis indicated no morphological changes induced to rat tissue upon 
adhesion of the strain indicating the safety of adhesion.  
E. mundtii ST4SA displays translocation in the cecum and colon of rat tissue. This 
is a common phenomenon of enterococci. However, only poses a problem if the 
organism elicits infection. Safety evaluation of strain ST4SA indicated no infection or 
detrimental health effects induced to Wistar rats. Histological analysis of the intestinal 
tissue indicated no morphological changes or deleterious effects. This denotes that 
translocation of the organism does not affect the tissue and organism as a whole. The 
strain also positively influences the natural microflora by inhibiting enterobacteria 
whilst not affecting the lactic acid bacterial content. The strong possibility of mannose 
receptors was observed for E. mundtii ST4SA, an important trait for potential 
probiotics.  
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Table 1. Strain-specific primers used in the design of probes to detect L. 
plantarum 423 and E. mundtii ST4SA. Primers were also used for real time PCR 
Primer set Sequence 5’to 3’ Size of amplicon (bp) 
 
Bac 423F RT 
Bac 423R RT 
 
Mund ST4SA F 
Mund ST4SA R 
 
 
GACATTTACATTGAGTAGGAACTAG 
GTAACCCCATTACCATAGTATTTAC 
 
ATGTCACAAGTAGTAGGTGG 
AGCTAAATTCGCAGCAGA 
 
 
147 
 
 
123 
 
 
 
 
Table 2. Quantification of strains by using real time PCR 
 
Strain Section Av. Ct Quant.* Set to calibrator# 
Duodenum 30.76 2.8 1
Ileum 25.99 60 22 423 
Cecum 25.76 70 26 
 Colon 30.84 2.7 1 
Jejenum 27.01 1.3 1
Ileum 26.29 2.1 1.6 ST4SA 
Cecum 19.21 251 193 
 Colon 22.26 32 24 
 
* Calculation of the quantity of each bacteriocin gene in specific tissue sections were 
determined by equations obtained in the standard curve. 
# Samples that contained the lowest quantity of the bacteriocin gene served as the 
calibrator sample.  
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FIG. 1. FISH images of L. plantarum 423 and E. mundtii ST4SA adhered to rat 
intestinal tissue under 600x magnification. Fluorescent images are shown on the left, 
phase images in the middle and overlayed images on the right. A: L. plantarum 423 
adhering to the cecum. Arrows indicate the strong fluorescent signal recorded along 
the epithelial lining. B: Strain 423 detected in the lumen content of the colon, with no 
binding to colonic tissue. C: FISH on cecum tissue of group D rats with probe 423. D: 
FISH indicating intracellular activity of strain ST4SA (indicated with arrows). E: 
E 
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FISH on cecum tissue of group D rats with probe ST4SA. L = lumen, a = apical side 
of the enterocyte, b = basal side of enterocyte, VC = villus core, g = goblet cell, e = 
enterocyte. 
 
 
  
 
FIG. 2. H&E stains of rat tissue. A: colonic tissue of rats administered with L. 
plantarum 423; B: colonic tissue of rats administered with E. mundtii ST4SA; C: 
colonic tissue of control rats; D: tissue from the ileum of rats administered with strain 
423; E: tissue from the ileum of rats administered with E. mundtii ST4SA; F: tissue 
from the ileum of control rats. No morphological changes can be visualized upon 
adhesion of the strains. 
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FIG. 3. Standard curves for Bac 423 and Mund ST4SA. Bac 423 (y = -3.5694x + 
32.361). Mund ST4SA (y = -3.361x + 27.353). 
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FIG. 4. DGGE profiles of lactic acid bacteria and Enterobacteriaceae in intestinal 
tissue samples, after treatment with L. plantarum 423 and E. mundtii ST4SA. DGGE 
profiles of intestinal tissue sample from group D rats served as the controls. A: Effect 
of strain 423 on the enterobacteriaceae (left to right, cecum, cecum control, colon, 
colon control); B: effect of strain ST4SA on the enterobacteriaceae (left to right, 
cecum, cecum control, colon, colon control); C: effect of strain 423 on the lactic acid 
bacteria population (left to right, cecum, cecum control, colon, colon control); D: 
effect of strain ST4SA on the lactic acid bacteria population (left to right, cecum, 
cecum control, colon, colon control).  
 
Stellenbosch University http://scholar.sun.ac.za
  
99
Chapter 5 
 
 
 
Surface proteins of Lactobacillus plantarum 423 may confer binding 
to Caco-2 cell lines and lead to competitive exclusion and 
displacement of Clostridium sporogenes LMG 13570 and 
Enterococcus faecalis LMG 13566 
 
Abstract 
Surface proteins of Lactobacillus plantarum 423 were characterized to 
determine their possible role in adhesion to Caco-2 cells. A multifunctional 
“intracellular” protein, elongation factor Tu (EF-Tu), glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) and triosephosphate isomerase (TPI) were 
detected. Removal of surface proteins reduced adherence of strain 423 to Caco-2 
cells by 40%, suggesting that these proteins play a role in adhesion. Adherence of 
Clostridium sporogenes LMG 13570 and Enterococcus faecalis LMG 13566 to 
Caco-2 cells were inhibited by 70% and 90% respectively, when incubated with 
strain 423. Strain 423 excluded C. sporogenes LMG 13570 from Caco-2 cells by 
73% and displaced the opportunistic pathogen by 80%. E. faecalis LMG 13566 
was excluded by 60% and displaced from Caco-2 cells by 90%. Despite removal 
of the surface proteins, L. plantarum 423 was still capable of competitively 
adhering to Caco-2 cells and reduced adherence of C. sporogenes LMG 13570 by 
50% and E. faecalis LMG 13566 by 70%. 
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Introduction 
Probiotic therapy has become an attractive alternative to overcome problems 
associated with antibiotics, such as emergence of multi-drug resistant pathogens. The 
complex mechanisms by which they function in eliminating pathogens, minimises the 
chances for the development of resistance against probiotics (16). In addition, the use 
of probiotics may possibly eliminate the need to re-establish the normal gut microflora 
as often required after antibiotic therapy (17, 38). Probiotics also benefit the host in a 
number of ways, for example stimulate the immune system (50), alleviate problems 
associated with inflammatory bowel diseases (27), reduce cholesterol levels (23) and 
lower high blood pressure (25). However, the most prevalent health benefit has been 
their role in the treatment of diarrhoea (5, 11, 42). This effect is dependent on the 
ability of probiotics to adhere to intestinal enterocytes and prevent colonisation of 
pathogens. Adhesion to the gastrointestinal tract is also a pre-requisite for potential 
probiotics to prevent elimination by peristalsis (34).  
Several functions have been proposed for lactobacilli surface proteins, one of 
which includes the role in cell adhesion and surface recognition (39, 45). The absence 
of an outer membrane and the presence of multiple peptidoglycan layers has resulted 
in different strategies for anchoring proteins to the cell surface (46). Three main 
strategies have been identified and they include covalent attachment (e.g., the LPXTG 
containing proteins) (36), charge interactions (e.g., Slp) (32) and hydrophobic 
interactions (30). Surface layer proteins (Slp) are regular structures covering the cell 
surface and are composed of monomeric protein units known as the S-protein (45). 
Common features of all lactobacilli Slp is their ability to spontaneously crystallize into 
a two dimensional structure outside the bacterial cell surface (44) and their extraction 
with charged reagents such as guanidine hydrochloride and lithium chloride (32). 
Genes encoding Slp of Lactobacillus acidophilus (9), Lactobacillus brevis (49), 
Lactobacillus helveticus (12) and Lactobacillus crispatus (43) have been sequenced. 
Slp have also been described for Lactobacillus amylovorus (8), Lactobacillus 
buchneri (19), Lactobacillus gallinarum (32), Lactobacillus kefir and Lactobacillus 
parakefir (33), but none of the genes encoding these Slp have been sequenced. L. 
acidophilus group B strains, Lactobacillus johnsonii and Lactobacillus gasseri do not 
appear to have characteristic Slp (8) but rather aggregation promoting factors (APF) 
(48). APF was removed by treatment with 5 M LiCl and displayed a high alkaline 
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isoelectric point. They also appear to be anchored by specific non-covalent 
interactions and share many characteristics with typical Slp of other lactobacilli (48).  
In addition to Slp and APF, anchorless multifunctional proteins have also been 
described for lactobacilli (4, 22). EF-Tu and GroEl are intracellular proteins that 
function in protein synthesis and protein folding. However, these proteins have been 
identified on the cell surface and culture medium of L. johnsonii La1 where they 
mediate adhesion to mucin and human epithelial cells (4, 22). EF-Tu and GroEl are 
referred to as anchorless multifunctional proteins as no established signal sequences or 
anchoring motifs are present in their predicted sequences (14). Surface enzymes such 
as PrtB of Lactobacillus delbrueckii subsp. bulgaricus, has been described (21). A 
novel bacterial surface protein, BspA, has also been identified in Lactobacillus 
fermentum strain BR11. This protein shares significant homology with family III of 
bacterial solute binding proteins (47).  
The role of surface proteins in conferring adherence of lactobacilli to human 
enterocytes, have been demonstrated for different species (10, 13). The present study 
characterized the surface proteins of L. plantarum 423 and determined the role in 
adhesion to Caco-2 cell lines. The ability of L. plantarum 423 to competitively 
exclude and displace Clostridium sporogenes LMG 13570 and Enterococcus faecalis 
LMG 13566 from Caco-2 cells was also investigated.  
 
Materials and methods 
Bacterial strains and culture conditions 
L. plantarum 423, Lactobacillus plantarum WCFS1 and Lactobacillus acidophilus 
ATCC 4356 were cultured in De Man Rogosa Sharpe (MRS) broth (Biolab, Biolab 
Diagnostics, Midrand, South Africa) at 37°C, without aeration. C. sporogenes LMG 
13570 was cultured in tryptone soy broth (TSB, Biolab) and E. faecalis LMG 13566 
in brain heart infusion broth (BHI, Biolab) at 37°C without aeration. L. plantarum 
423, C. sporogenes LMG 13570 and E. faecalis LMG 13566 were cultured for 18 h 
until OD600 = 1.8, which is equivalent to approximately 1 × 106 CFU/ml. Cells were 
harvested (10000 × g, 10 min, 4oC), washed twice with PBS and resuspended in 100 
µl PBS for adhesion assays. 
SDS-PAGE of surface proteins, purification and characterization  
L. plantarum 423, L. plantarum WCFS1 and L. acidophilus ATCC 4356 were 
inoculated into 10 ml of MRS broth (Biolab) and cultured for 18 h (OD600 = 1.8). 
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Cells were harvested (10000 × g, 10 min, 4oC) and washed twice with ice-cold sterile 
distilled water. Cells were treated with 2 ml 4 M guanidine-HCl for 1 h and 2 ml 5 M 
LiCl for 30 min. Both reactions were incubated at 37°C (9). Supernatants were 
separated by SDS-PAGE (10%, w/v) as described by Laemmlli (29). Protein bands 
were visualised by silver staining using the ProteoSilverTM Plus Silver Stain Kit 
(Sigma, Steinheim, Germany). Bands with molecular weights between 20 and 45 kDa 
were excised, destained with the ProteoSilverTM Plus Silver Stain Kit (Sigma) and 
prepared for identification by mass spectrometry, according to the method of 
Shevchenko et al. (41). Intact protein bands were digested with sequencing grade 
modified trypsin (Promega, Madison, USA). The procedure included reduction and 
acetamidation steps prior to tryptic digestion (41). Digested peptides were analysed 
with Waters API Q-TOF Ultima fitted with a Waters CapLC Gradient and an Atlantis 
dC18 Column. 5 µl samples were injected at a flow rate of 200 nl/min. Purification 
and characterization of surface proteins were performed in duplicate. 
Culturing of Caco-2 cells 
Caco-2 cells (Highveld Biological Pty. Ltd., Kelvin, Johannesburg) were cultured 
in Minimal Essential Medium (MEM) Earle’s Base (Highveld Biological), 
supplemented with 10% (v/v) fetal bovine serum (Sigma), 100 U ml-1 penicillin and 
100 U ml-1 streptomycin (Sigma), in the presence of 5% CO2. Cells were cultured in 
12-well plates (MultiwellTM, Becton Dickinson Labware, NJ, USA) at 1 × 105 cells per 
well at 37°C, until confluency. 
Competitive, exclusion and displacement adhesion assays 
Surface proteins of L. plantarum 423 were removed by treatment with 4 M 
guanidine-HCl for 30 min prior to adhesion assay to determine their role in adherence 
to Caco-2 cells. 100 µl (approximately 1 × 106 cfu) of L. plantarum 423 (with and 
without surface proteins) was added to Caco-2 cells (1 x 105 Caco-2 cells per well) in 
separate wells and incubated for 2 h at 37°C. After incubation, bacterial cells were 
withdrawn from the wells and Caco-2 cells were washed twice with 1 ml sterile PBS. 
Adhering cells were treated with 1 ml 0.5% (v/v) Triton X-100 for 3 min on ice, 
followed by serial dilutions and plating onto MRS agar (Biolab). 
Competition for adherence of L. plantarum 423 (with and without surface 
proteins), C. sporogenes LMG 13570 and E. faecalis LMG 13566 to Caco-2 cells 
were studied by inoculating each well (1 × 105 Caco-2 cells) with 100 µl 
(approximately 1 × 106 cfu) of strain 423 and 100 µl (approximately 1 × 106 cfu) of 
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either C. sporogenes LMG 13570 or E. faecalis LMG 13566. After 2 h incubation at 
37°C, the bacterial cells were withdrawn from the wells and the Caco-2 cells washed 
with two volumes of 1 ml sterile PBS, followed by treatment with 1 ml 0.5% (v/v) 
Triton X-100. Ten-fold dilutions of adhering bacterial cells were prepared and plated 
onto MRS agar (Biolab) for enumeration of L. plantarum 423, on TSB (Biolab) plates 
for C. sporogenes LMG 13570 and on BHI (Biolab) plates for E. faecalis LMG 
13566.  
The ability of L. plantarum 423 to competitively exclude each opportunistic 
pathogen from adhering to Caco-2 cells was determined by inoculating each well (1 × 
105 Caco2 cells) with 100 µl of strain 423 (approximately 1 × 106 cfu). After 1 h of 
incubation at 37oC, 100 µl of either C. sporogenes LMG 13570 or E. faecalis LMG 
13570 was added to L. plantarum 423 in separate wells and incubated for a further 60 
min. Non-adhering cells were removed by washing twice with sterile PBS, followed 
by treatment with 0.5% (v/v) Triton X-100, serially diluted and plated out onto the 
respective agar media. 
In a separate experiment, the ability of L. plantarum 423 to displace C. sporogenes 
LMG 13570 and E. faecalis LMG 13570 from Caco-2 cells was determined by first 
incubating Caco-2 cells with 100 µl of either C. sporogenes LMG 13570 or E. faecalis 
LMG 13570 for 1 h at 37oC, followed by incubation in the presence of L. plantarum 
423 for a further 60 min. Cells were serially diluted and plated onto respective agar 
media. All adhesion assays were performed in triplicate. 
 
Results 
SDS-PAGE of surface proteins, purification and characterization 
L. plantarum 423 does not possess an apparent S-layer protein as present in most 
Lactobacillus spp. Treatment of bacteria with LiCl is a routine procedure to extract S-
layer proteins. However, treatment of L. plantarum 423 with LiCl yielded only a few 
proteins, with the highest molecular weight approximately 20kDa. This indicated no 
evidence for the presence of a distinct S-layer protein (Fig. 1). Treatment of cells with 
guanidine-HCl proved more efficient, as observed by a greater variety of proteins 
being extracted (Fig. 1). 
Dominant protein bands 1, 2 and 3 of L. plantarum 423 (lane 6, Fig. 1) were 
excised, purified and characterized by mass spectrometry and Mascot MS/MS ion 
searches. In the latter, confidence that a protein has been identified correctly may be 
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derived from multiple matches to peptides from a subject protein in the database. The 
score is based on an absolute probability (P) that the match between the protein in 
question and the subject protein in the database is a random event. Therefore, the 
higher the score the greater the chance the match is not a random event. Results 
indicated that band 1 reflected significant homology to the elongation factor Tu (EF-
Tu) of other L. plantarum strains, as depicted by a score of 443. Band 2 revealed 
extensive homology to the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
protein of other L. plantarum strains with a score of 471. Band 3 indicated homology 
to triosephosphate isomerase (TPI) of other L. plantarum strains with a score of 110. 
In addition, molecular sizes of the proteins correlated well with the respective matches 
in the database, confirming the identity of the proteins. 
Competitive, exclusion and displacement adhesion assays  
Treatment of L. plantarum 423 with guanidine-HCl reduced adhesion of the strain 
to Caco-2 cells by 40%. L. plantarum 423 demonstrated its probiotic potential by 
inhibiting the adherence of C. sporogenes LMG 13570 and E. faecalis LMG 13566 to 
Caco-2 cells by 70% and 90%, respectively. Strain 423 excluded C. sporogenes LMG 
13570 by 73% and displaced the pathogen by 80%. E. faecalis LMG 13566 was 
excluded by 60% and displaced by 90%. Despite the removal of the surface proteins, 
L. plantarum 423 was still capable of competitively adhering to Caco-2 cells and 
reduced adherence of C. sporogenes LMG 13570 by 50% and E. faecalis LMG 13566 
by 70%. 
 
Discussion 
L. johnsonii and L. gasseri are two Lactobacillus spp. previously reported to not 
possess a distinct Slp (8). Both species contain novel surface proteins (APF) which 
share similar characteristics to typical Slp of most lactobacilli (48). The present study 
emphasizes the absence of a Slp in another Lactobacillus species, L. plantarum. 
Characterization of surface proteins of L. plantarum 423 revealed the presence of an 
“intracellular” multifunctional protein (EF-Tu) and surface glycolytic enzymes 
(GAPDH and TPI). EF-Tu, GAPDH and TPI do not contain a signal sequence or 
anchoring motif in their predicted sequences to explain their presence on the surface 
of the bacterium. The mechanism of adherence of these proteins to the surface of the 
producer cell is not well understood. However, their detection on the surfaces of other 
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Gram-positive bacteria have been reported (3, 22). These proteins were removed by 
treatment with guanidine-HCl, suggesting non-covalent attachment to the cell wall.  
The EF-Tu protein binds to GTP and functions during protein synthesis (20). 
Initially it was thought that the molecule is restricted to within the cytoplasm of 
prokaryotes. However, later studies have shown that the EF-Tu molecule is also 
associated with the membrane of E. coli (28) and the periplasm of Neisseria 
gonorrhoeae (37). In lactobacilli, EF-Tu may function as an “envelope associated 
protein”, which may be released from cells during osmotic shock (35). The role of EF-
Tu as an adhesion molecule was described for L. johnsonii La1 (NCC 533) when the 
molecule mediated attachment of the strain to Caco-2 cells and mucus. The 
importance of the protein in mediating attachment was reflected by the ability of the 
purified protein to inhibit binding of strain La1 to mucin by up to 40% (22). In 
addition, the EF-Tu protein of L. johnsonii NCC 533 shares 84% homology with an 
EF-Tu protein isolated from L. plantarum, suggesting functional similarity between 
these molecules (22). Up-regulation of EF-Tu in the presence of mucus suggests that 
this molecule participates as a major adhesin in L. plantarum 423. 
GAPDH functions in glycolysis, catalyzing the breakdown of glucose to release 
carbon as an energy source. However, other functions for the enzyme, such as 
activation of transcription (51) and initiation of apoptosis (24) have been described. 
The position of the enzyme on the surface of Gram-positive bacteria has also been 
depicted, with involvement in pathogen-host interactions (3, 7, 40). GAPDH has also 
been detected in the cytoplasmic fraction and cell surface of Streptococcus 
pneumoniae (3). Recent studies have shown that some strains of L. acidophilus and L. 
crispatus have GAPDH as a major constituent of their extracellular proteome (26). 
The GAPDH of L. crispatus ST1 binds to lipoteichoic acid (LTA) at very low pH, 
suggesting that negatively charged LTA may be involved in the anchoring of the 
protein to surfaces (1). TPI also functions in the glycolytic pathway, catalyzing the 
reversible interconversion of triose phosphate isomers facilitating efficient energy 
production (2). Genome analysis of L. plantarum WCFS1 revealed over 200 putative 
extracellular proteins with 57 predicted to be secreted into their surrounding medium 
or associated to the cell wall by unknown mechanisms (6). This indicates the 
importance of extracellular proteins in the cross-talk between lactobacilli and their 
host. Surface enzymes such as GAPDH and TPI can be classified as multifunctional 
proteins that may be released from the cell and assist the organism to adapt to changes 
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in the environment. Hence, GAPDH and TPI of L. plantarum 423 may function as 
adhesins which play a crucial role in colonisation of the organism to its environment. 
Caco-2 cells express several markers that are distinctive of normal small intestinal 
villi and have served as excellent in vitro models for understanding the mechanisms 
involved in adherence of probiotic bacteria and invasion of pathogens, as depicted by 
the number of reviews (15, 18, 22, 31). Caco-2 cells provide an excellent system for 
understanding not only the mechanisms by which commensals adhere to the intestine 
but also how these bacteria interact with pathogens that compete in the same 
environment. L. plantarum 423 portrayed exceptional probiotic potential by 
competitively adhering to Caco-2 cells and reduced the adherence of C. sporogenes 
LMG 13570 and E. faecalis LMG 13566 significantly. The strain was more successful 
in displacing both opportunistic pathogens from Caco-2 cells. This is important 
attribute for a potential probiotic for counteracting an adhering pathogen in the case of 
infection.  
Conclusions 
Lactobacillus plantarum 423 does not possess a Slp, but a multifunctional protein, 
EF-Tu and glycolytic enzymes GAPDH and TPI were detected. Recent evidence has 
shown the presence of these proteins on surfaces of Gram-positive bacteria and 
additional functions have been described. EF-Tu, GAPDH and TPI can be classified 
as multifunctional proteins that are released from the cell to assist L. plantarum 423 
with adapting to changes in the environment. Removal of surface proteins reduced 
adherence of strain 423 to Caco-2 cells by 40% suggesting that EF-Tu, GAPDH and 
TPI may function as adhesins in L. plantarum 423. Strain 423 exhibited excellent 
probiotic potential by competitively adhering to Caco-2 cells in the presence of C. 
sporogenes LMG 13570 and E. faecalis LMG 13570. More importantly, strain 423 
displaced C. sporogenes LMG 13570 by 80% and E. faecalis LMG 13570 by 90%.  
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FIG. 1. SDS-PAGE of surface proteins of L. plantarum 423. Lane 1: High range 
protein molecular weight marker; lanes 2 and 3: Guanidine-HCl extraction of L. 
plantarum WCFS1; lane 4: LiCl extraction of L. plantarum WCFS1; lane 5: LiCl 
extraction of L. plantarum 423; lanes 6 and 7: Guanidine-HCl extraction of L. 
plantarum 423; lane 8: Guanidine-HCl extraction of L. acidophilus ATCC 4356. Band 
1 is EF-Tu, band 2 is GAPDH and band 3 is TPI. 
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Chapter 6 
 
 
 
Discussion and concluding remarks 
 
General discussion and conclusions 
The human gastrointestinal system is inhabited by a dynamic and complex 
microbial ecosystem. The advent of molecular techniques has facilitated a greater 
understanding of the complex mechanisms that occur in bacterial-host interactions and 
as a result we have gained a greater appreciation for the indigenous microflora 
(probiotics). Much attention has focused on the molecular basis of crosstalk between 
enteric pathogens and the intestinal epithelium (4-7). Excluding stimulation of the 
immune system, the molecular mechanisms of probiotic adhesion, still remain largely 
unknown. Advances in molecular technology will undoubtedly contribute to this area 
of research and provide superior quantitative and qualitative analysis on the adhesive 
properties of potential probiotics. The present study aimed to contribute to this area of 
research and reports on the use of current molecular techniques to provide insight on 
the molecular mechanisms of adhesion of potential probiotic strains Lactobacillus 
plantarum 423 and Enterococcus mundtii ST4SA.  
Probiotic adhesion to host tissue is mediated by non-specific mechanisms 
(hydrophobic interactions and electrostatic forces) and specific interactions involving 
protein or carbohydrate molecules. The latter has proven critical for probiotic action 
as these molecules recognise receptors that may also be specific for the colonisation of 
pathogens. In addition to phenotypic evaluation of the adhesive potential of a 
probiotic, detection of genes encoding these adhesive molecules should also become a 
focus to determine the ability of a particular probiotic to target specific receptors. 
Research on the expression of these genes under digestive stress conditions should 
also be a priority as, although it may be useful to ascertain the presence of these genes, 
it may serve no purpose if these genes are not up-regulated under appropriate 
conditions. 
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This study encompasses the first report on expression of mucus adhesion genes 
under digestive stress conditions in vitro. Results concluded that L. plantarum 423 
possess all the necessary requirements to be an efficient probiotic. Mucus adhesion 
genes mub, mapA and EF-Tu were detected and the genes were expressed under 
different conditions, indicating the ability of the strain to adapt to physiological 
conditions and adhere to the gastrointestinal tract.  
A general functional role for Slp have not been described. Several functions have 
been proposed, including surface recognition and cell adhesion. The Slp of L. 
crispatus ZJ001 contributed to adhesion of the strain to HeLa cells. Functional role of 
the Slp in adhesion was confirmed by an antibody-mediated inhibition assay with 
polyclonal antibodies (2). In the present study, the role of the Slp in adhesion to 
mucus was investigated for L. acidophilus ATCC 4356. slp was not up-regulated in 
the presence of mucus, but was expressed under normal and stressful gut conditions in 
vitro. Characterization of the surface proteins of L. plantarum 423 did not reveal the 
presence of Slp. Despite the lack of Slp strain 423 efficiently adhered to Caco-2 cell 
lines and enterocytes of rats. These data reveal that the Slp may contribute to the 
adhesion of certain strains to cell surfaces. The present study does not support Slp as a 
major contributor to adhesion of probiotics to host surfaces. Investigation of the 
surface proteins of L. plantarum 423 revealed EFTu, GAPDH and TPI to be major 
contributors to adhesion of the strain to Caco-2 cells. EFTu was up-regulated in the 
presence of mucus and is present on the surface of the strain. This suggests that EFTu 
may function as a novel adhesin in L. plantarum 423. It can be concluded that L. 
plantarum 423 possesses all the genetic requirements necessary to be an efficient 
coloniser of the GIT and exhibits exceptional characteristics as a future probiotic. 
Numerous studies have incorporated radioactive labeling as a sensitive means of 
analysis for monitoring adhesion of probiotics to mucus or cell lines (3, 8, 10). Real 
time PCR is a safe, rapid and sensitive technique that negates the dangers associated 
with radioactive labeling. A previous study utilized the technique to quantify the 
adhesion of Bifidobacterium spp. to Caco-2 cells and also outlined advantages of the 
technique in comparison to radioactive labeling (1). In the present study quantitative 
real time (qRT) PCR was successfully applied to evaluate adhesion gene expression of 
L. plantarum 423 and quantify strain 423 and E. mundtii ST4SA in the gastrointestinal 
tract of male Wistar rats. In addition to in vitro applications, the technique proved 
successful in vivo for delivering accurate data within a short space of time and avoided 
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the tediousness associated with conventional culture based methods. The present study 
supports the use of RT PCR as a robust technique that delivers precise, reproducible 
quantitative and qualitative data. The technique should be applied more regularly in 
future applications.  
Examination of the adhesive potential of a probiotic should extend beyond 
phenotypic evaluation to gain a greater perspective on how the microorganism 
functions. FISH conducted on formaldehyde fixed tissue of rats administered with E. 
mundtii ST4SA revealed translocation of the strain. Translocation of enterococci is a 
common phenomenon and has been described previously (11, 12). However, this may 
only pose a problem if the organism elicits infection. Safety evaluation of E. mundtii 
ST4SA concluded the strain to be safe for human consumption (9). However, to 
reduce any possible risk that may be associated with the translocation of strain 
ST4SA, suggestions into the use of the purified antimicrobial peptide for future 
probiotic applications could be considered. This would have not been evident by only 
taking phenotypic studies into consideration. Molecular genome-based approaches 
provide greater insight on the functional properties of a probiotic and allows for a 
more selective view for their probiotic action.  
 
Future recommendations  
Understanding the full potential of probiotics for therapeutic applications requires 
thorough investigations on molecular mechanisms of probiotic action, particularly 
interactions with the host. Enhanced understanding of these molecular interactions 
will also enable researchers to foresee any possible adverse effects that may be 
generated by a particular probiotic. This will permit for the selection of the best strains 
that target specific problems, whilst simultaneously eliminating possible associated 
risks. Molecular analytical tools such as real time PCR and FISH serve as versatile, 
highly-sensitive techniques for delivering rapid data in a variety of in vitro and in vivo 
applications. The techniques were successfully applied in understanding the molecular 
mechanisms of adhesion of L. plantarum 423 and E. mundtii ST4SA.  
Research goals of the present study addressed key issues with regards to 
evaluating the adhesion of probiotics to host tissue. Although the objectives have been 
achieved, greater emphasis is required in this area of research. Future 
recommendations will encompass characterising novel surface proteins of L. 
plantarum 423 and evaluate specific interactions of these proteins with host surface 
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receptors. Inactivation of the adhesion genes and competitive experiments with 
specific pathogens should provide a greater perspective on the specificity of these 
genes in combating a particular pathogen. Stimulation of the immune system by strain 
ST4SA should be considered for future research to determine if translocation of the 
strain exhibits a positive influence to the host. 
Unraveling the intricacies of probiotic host interactions will provide greater insight 
on the functional attributes of these remarkable microorganisms. This will allow for 
industry and consumers to choose scientifically validated probiotics as a natural 
alternative for overcoming various health problems. 
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Expression of the mucus adhesion genes Mub and MapA, adhesion-like
factor EF-Tu and bacteriocin gene plaA of Lactobacillus plantarum 423,
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Expression of the mucus adhesion genes Mub and MapA, adhesion-like factor EF-Tu and bacteriocin gene plaA by Lactobacillus plantarum
423, grown in the presence of bile, pancreatin and at low pH, was studied by real-time PCR. Mub, MapA and EF-Tu were up-regulated in the
presence of mucus, proportional to increasing concentrations. Expression of MapA was up-regulated in the presence of 3.0 g/l bile and 3.0 g/l
pancreatin at pH 6.5. Similar results were recorded in the presence of 10.0 g/l bile and 10.0 g/l pancreatin at pH 6.5. Expression ofMub was down-
regulated in the presence of bile and pancreatin, whilst the expression of EF-Tu and plaA remained unchanged. Expression of Mub and MapA
remained unchanged at pH 4.0, whilst expression of EF-Tu and plaAwere up-regulated. Expression of MapAwas down-regulated in the presence
of 1.0 g/l l-cysteine HCl, suggesting that the gene is regulated by transcription attenuation that involves cysteine.
© 2007 Elsevier B.V. All rights reserved.Keywords: Lactobacillus plantarum; Gene expression; Real-time PCR1. Introduction
Lactic acid bacteria are regarded probiotic if they success-
fully compete with intestinal pathogens and restore the normal
microbiota. One of the first biological barriers encountered by
probiotic bacteria is low pH in the stomach. Those cells that
survive such extreme conditions are exposed to further stress in
the small intestine, inflicted by bile salts and pancreatic juice
(Bron et al., 2004).
Probiotic bacteria compete with intestinal micro-organisms
for adhesion to mucus and epithelial cells by production of
antimicrobial agents such as organic acids, diacetyl, hydrogen
peroxide and bacteriocins (Klaenhammer, 2000; Morelli, 2000;
Saarela et al., 2000). A few strains produce specific adhesion
proteins. The best studied examples are the mucus adhesion-
promoting protein (MapA; Genebank accession number AJ
293860) and the mucus-binding protein (Mub) produced by
Lactobacillus reuteri (Roos and Jonsson, 2002). Five proteins⁎ Corresponding author. Tel.: +27 21 8085849; fax: +27 21 8085846.
E-mail address: lmtd@sun.ac.za (L.M.T. Dicks).
0168-1605/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.ijfoodmicro.2007.02.011homologous to the Mub protein of L. reuteri 104R have been
described for Lactobacillus acidophilus NCFM (Alterman
et al., 2005). Mub homologues have also been reported for
Lactobacillus gasseri, Lactobacillus johnsonii and Lactobacil-
lus plantarum (Alterman et al., 2005).
The collagen binding protein (CnBP) produced by L. reuteri
interacts with mucin but does not play a role in adhesion
(Aleljung et al., 1994; Roos et al., 1996). An adhesion-like
protein, classified as elongation factor Tu (EF-Tu), was isolated
from L. johnsonii NCC 533 (La1) (Granato et al., 2004). EF-Tu
facilitates the transfer of aminoacyl-tRNA to the A-site of
ribosomes (Gaucher et al., 2001). The EF-Tu protein also binds
to mucin and mediates colonisation of strain NCC 533 to human
intestinal cells andmucus (Granato et al., 2004). The mechanism
by which EF-Tu interacts with mucin is not well understood. An
EF-Tu protein isolated from L. plantarum shared 84% homology
with the EF-Tu protein of L. johnsonii NCC 533 (Granato et al.,
2004).
L. plantarum is used as a starter culture in the production of
several types of fermented foods and is considered a natural
inhabitant of the intestinal tract (Ahrne et al., 1998). Strain 423,
Table 2
Primers used in the study
Primer set Sequence 5′ to 3′ Size of amplicon
(bp)
Bac 423F RT GACATTTACATTGAGTAGGAACTAG 147
Bac 423R RT GTAACCCCATTACCATAGTATTTAC
Mub 423F RT GTAGTTACTCAGTGACGATCAATG 150
Mub 423R RT TAATTGTAAAGGTATAATCGGAGG
Map 423F RT TGGATTCTGCTTGAGGTAAG 156
Map 423R RT GACTAGTAATAACGCGACCG
EFTu 423F RT TTCTGGTCGTATCGATCGTG 161
EFTu 423R RT CCACGTAATAACGCACCAAC
GDPH 423F RT ACTGAATTAGTTGCTATCTTAGAC 140
GDPH 423R RT GAAAGTAGTACCGATAACATCAGA
406 K. Ramiah et al. / International Journal of Food Microbiology 116 (2007) 405–409isolated from sorghum beer (Van Reenen et al., 1998) produces
a bacteriocin, plantaricin 423, resistant to treatment at 80 °C and
incubation in MRS broth at pH 1.0 to 10.0 (Van Reenen et al.,
1998). The genes encoding plantaricin, a typical class IIa pep-
tide, have been sequenced (Van Reenen et al., 2003). The
peptide is active against food-borne pathogens, including Ba-
cillus cereus, Clostridium sporogenes, Enterococcus faecalis,
Listeria spp. and Staphylococcus spp. (Van Reenen et al.,
1998). Strain 423 survived gastro-intestinal conditions si-
mulated in an in vitro model and adhered to intestinal mucus
(unpublished data).
Previous studies focussed mainly on physiological aspects,
such as in vitro adhesion of probiotic cells to CaCo-2 cell lines or
mucus (Tuomola et al., 2000; Apostolou et al., 2001; Ouwehand,
2005). Little is known about the expression of genes involved in
adhesion, especially when cells are exposed to stress conditions
simulating the gastro-intestinal tract. The present study looks at
the expression of Mub, MapA, EF-Tu and the structural gene of
plantaricin 423 (plaA) when the strain is cultured in the presence
of bile salts, pancreatic juice and low pH. Expressions of these
genes were monitored by using real-time PCR.
2. Materials and methods
2.1. Bacterial strains and culture conditions
L. plantarum 423, isolated from sorghum beer (Van
Reenen et al., 1998), was cultured in De Man Rogosa Sharpe
(MRS) broth (Biolab, Biolab Diagnostics, Midrand, South
Africa) at 37 °C. Gene expression studies were done in MRS
broth (Biolab), supplemented with mucin, bile and pancreatin
(Table 1). Regulation of the MapA gene was studied in MRS
broth (Bioloab), supplemented with 0.1% (w/v) l-cysteine
HCl.
2.2. Primer design and PCR
Primers used in this study are listed in Table 2. Primers for
the amplification of plaA were designed from the structural
gene encoding plantaricin 423 (Van Reenen et al., 2003). All
other primer sequences were designed from the genome
sequence published for L. plantarum WCFS1 (accession
number NC 004567). Primers were designed with the Primer
Designer Program, version 1.01 (Scientific and EducationalTable 1
Modification of MRS broth (Biolab) to simulate gastric conditions
Mediuma Mucin % (w/v)b Bile % (w/v) Pancreatin % (w/v) pHc
1 0 0 0 7
2 0.01 0 0 7
3 0.05 0 0 7
4 0.01 0.3 0.3 6.5
5 0.01 1.0 1.0 6.5
6 0.01 0.3 0.3 4
aMedium 4 simulates normal gut conditions and media 5 and 6 stress conditions.
bPorcine mucus (Sigma, Mannheim, Germany).
cAdjusted with 0.5 M HCl.Software). The GC-content of the primers ranged between 30
and 40% and the Tm from 55 to 65 °C. Primer sets were
designed to produce an amplicon of approximately 150 bp.
Primer dimer formation was checked by agarose gel electro-
phoresis (2% agarose) and melting curve analysis. A standard
curve consisting of the Log template concentration of DNA
plotted against the Ct value (crossing points of different stan-
dard dilutions) was constructed for each primer set. Efficien-
cies were calculated by E=10(−1 / S)−1, where S=slope of the
standard curve.
2.3. RNA isolation and cDNA synthesis
Total RNA was isolated from 500 μl of an 18-h-old culture
(OD600=approximately 4.0), by using the RNeasy Mini Kit
(Qiagen, Valencia, California, USA). RNAwas stabilised in two
volumes of RNA protect bacteria reagent (Qiagen), prior to
isolation. Cells were harvested (5000×g, 10 min, 4 °C) and lysed
by incubation with lysosyme (6 μl of 50 mg/ml lysosyme per
100 μl of TE buffer) for 20 min at 37 °C. RNAwas resuspended
in 40 μl DEPC-treated H2O. Residual DNA was removed with
turbo DNase treatment, according to the instructions from the
supplier (Ambion, USA). RNA concentrations weremeasured in
triplicate using a NanoDrop spectrophotometer (Inqaba Biotec,
USA). Exactly 0.2 μg RNA was transcribed into cDNA, using
the Transcriptor First Strand cDNA Synthesis Kit (Roche
Diagnostics, Mannheim, Germany) and gene specific primers.
The reaction took 30 min at 55 °C.
2.4. Real-time PCR
The standard curve method was used for quantification as the
efficiencies between the targets and the reference gene were not
comparable (Giulietti et al, 2001). Standard curves were
constructed by plotting the Ct-value against the log template
value of cDNA of each gene. Target concentrations were ad-
justed by normalising against the glyceraldehyde-3-phosphate
gene, which served as endogenous reference, by dividing the
average concentration of target DNA by the average concentra-
tion of reference DNA. The relative gene expression levels were
compared by dividing the normalised target concentration by the
control sample (cells grown in MRS, medium 1), and vice versa.
Fig. 2. Standard curves of glyceraldehyde-3-phosphate for the different genes.
EF-Tu (y=−3.766x+27.796), Mub ( y=−3.58x+27.958), MapA ( y=
−3.504x+30.72), plaA ( y=−3.346x+27.952).
Table 3
Expression of Mub, MapA, EF-Tu and plaA, as recorded by real-time PCR
Genes Mediuma Av.
Ctb
Amt. GDPH
Av. Ct
Amt. Normalised Set to
control
407K. Ramiah et al. / International Journal of Food Microbiology 116 (2007) 405–409Real-time PCR reactions were performed in a LightCycler
instrument (Roche), with Relative Quantification Software
(version 5.32; Roche) and SYBR Green technology (Sigma).
Each 20 μl reaction mixture consisted of 10 μl SYBR Green
Supermix, 1 μl of each primer at 5 μmol, 7 μl nuclease-free
water and 1 μl diluted cDNA. Five dilutions of cDNA were
prepared for the standard curves. A negative control was
included in each run. Synthesis of cDNA and real-time PCRwas
performed in triplicate for each gene. The PCR conditions were
as follows: initial denaturation at 95 °C for 15 min, followed by
40 cycles of amplification at 50 °C for 10 s and 72 °C for 15 s.
At the end of each run a melting curve was performed from
95 °C to 45 °C (0.2 °C s−1).
3. Results
All primers and standard curves displayed an efficiency of
between 80 and 100% (Figs. 1 and 2). A single product-specific
melting curve was obtained for each primer set, which indicates
that primers were designed with optimal efficiency and were
effective in targeting and amplifying only the genes of interest.
L. plantarum 423 survived exposure to 0.5 M HCl at pH 2.0.
3.1. Expression of Mub
Genes are considered to be up- or down-regulated if their
relative expression levels are at least two-fold higher or lower
respectively, compared to the control sample or the calibra-
tor (Desroche et al., 2005). The Mub gene was expressed
approximately 80-fold more when grown in the presence of
0.01% (w/v) mucin and 144-fold more when grown in the
presence of 0.05% (w/v) mucin (Table 3). However, the gene
was suppressed when cells were grown under normal gut
conditions (0.3%, w/v, bile and 0.3%, w/v, pancreatin, pH 6.5)
and conditions simulating stress (1%, w/v, bile and 1%, w/v,
pancreatin, pH 6.5). Expression was down-regulated approxi-
mately seven-fold under normal intestinal conditions and aboutFig. 1. Standard curves of the different genes.Mub (y=−3.356x+30.302), EF-Tu
(y=−3.664x+26.952), plaA ( y=−3.88x+28.218),MapA (y=−3.876x+32.68).30-fold under stressful conditions. Expression ofMub remained
unchanged at pH 4.0.
3.2. Expression of MapA
TheMapA gene was up-regulated when cells were incubated
in the presence of mucin. Expression was six- and eight-fold
higher in the presence of 0.01% (w/v) mucin and 0.05% (w/v)
mucin, respectively (Table 3). TheMapA gene was significantly
up-regulated under normal and stressful conditions. Under nor-
mal conditions, MapA was expressed 25-fold higher compared
to the control (cells grown in MRS). However, under stressfulMub 1 24.98 38.9 21.64 57.5 0.68 1
2 24.5 53.7 27.93 1 53.7 80
3 23.61 97.7 27.91 1 97.7 144
4 25.28 31.6 19.19 316 0.1 7
5 27.86 5.4 18.88 316 0.02 34
MapA 1 26.4 41.7 21.62 398.1 0.1 1
2 25.78 60.3 23.64 104.7 0.6 6
3 25.73 61.7 24.16 74.1 0.8 8
4 26.95 30.2 26.94 12.02 2.5 25
5 27.1 27.5 25.91 23.4 1.2 12
EF-Tu 1 20.3 66.1 22.76 21.9 3 1
2 19.36 117.5 28.06 1.2 97.9 33
3 17.63 346.7 27.94 1.1 315.2 105
4 17.85 302 18.64 269 1.1 2.7
5 17.44 398 18.48 295 1.3 2.3
plaA 1 20.62 91.2 23.97 15.5 5.8 1
2 20.21 114.8 23.89 16.2 7.1 1.2
3 20.19 117.5 24.42 11.5 10.2 1.8
4 24.3 10 27.45 1.4 7.1 1.2
5 22.36 32.4 26.58 2.6 12.5 2.2
aSee composition in Table 1.
bAv. Ct=average crossing point at which a significant increase in fluorescence is
detected.
408 K. Ramiah et al. / International Journal of Food Microbiology 116 (2007) 405–409conditions,MapAwas expressed 12-fold higher (Table 3). At pH
4.0, the gene was up-regulated twice as much compared to
the control sample. In the presence of 0.1% (w/v) l-cysteine
HCl, MapA was considerably down-regulated (approximately
17-fold).
3.3. Expression of EF-Tu
EF-Tu was induced when cells were grown in medium
supplemented with mucus. The gene was expressed 33-fold
higher in the presence of 0.01% (w/v) mucin and approximately
100-fold higher in the presence of 0.05% (w/v) mucin (Table 3).
Expression of the gene was not affected by varying concentra-
tions of bile and pancreatin. Cells grown at pH 4.0 expressed
EF-Tu six-fold higher compared to cells grown under normal
conditions.
3.4. Expression of plaA
Expression of plaA was not influenced by changes in bile,
pancreatin and pH (Table 3).
4. Discussion
Colonisation of the intestinal tract is considered a prerequisite
for probiotic bacteria (Ouwehand et al., 1999a). Most studies
report on the adhesion of probiotic bacteria to intestinal cell lines
(Adlerberth et al., 1996; Granato et al., 1999; Dunne et al.,
2001). Although this may be a useful indication of adhesion, it is
not always a reflection of the ability of the bacteria to adhere to
mucus covering the intestinal cells (Ouwehand et al., 1999b).
The mucus layer serves a dual function. It may prevent the
adhesion of pathogenic bacteria, thereby protecting the intestinal
cells, but also serves as a nutrient source and matrix for colo-
nisation of probiotic bacteria (Nielsen et al., 1994). Adhesion to
mucosa is important for proliferation of probiotic cells, es-
pecially in the small intestine with high flow rates (Wadstrom,
1998). Furthermore, adhesion stimulates the immune system
(Ouwehand et al., 1999b). In at least one study (Elliot et al.,
1998), it has been claimed that damaged gastric mucosal cells are
repaired by the adherence of probiotic lactobacilli.
From first studies, it was concluded that the EF-Tu molecule
is restricted to the cytoplasm of prokaryotes. However, later
studies have shown that this molecule is also associated with the
membrane of E. coli (Jacobson and Rosenbusch, 1976) and the
periplasm of Neisseria gonorrhoeae (Porcella et al., 1996). In
lactobacilli, EF-Tu may function as an “envelope associated
protein,”which may be released from the cell when the organism
experiences osmotic shock (Nakamura et al., 1997). Granato
et al. (2004) demonstrated the presence of EF-Tu on the outer
surface of five Lactobacillus and two Bifidobacterium strains.
The concentration of EF-Tu on the surface of the strains differed,
suggesting possible differences in expression (Granato et al.,
2004). In this study, up-regulation of EF-Tu in the presence of
mucus suggests that the EF-Tu molecule may also play a role in
adhesion. This correlates well with work done by Granato et al.
(2004).Under normal physiological concentrations of bile and pan-
creatin, expression of the Mub gene was affected, the MapA
gene was over-expressed and the EF-Tu gene remained stable.
Similar results were obtained when L. plantarum 423 was ex-
posed to digestive stress. This suggests that, whilst the ex-
pression of certain mucus genes may be affected by bile and
pancreatin, other mucus genes are switched on, enabling the
strain to adapt to physiological conditions and adhere to the
gastro-intestinal tract.
The pH of the gut lumen is 6.5, but it has been postulated that
it becomes slightly more acidic closer to the mucus-covered
surface, owing to the sulfated content and sialic residues of
mucin (Blum et al., 2000; Granato et al., 2004). Hence, ex-
pressions of the adhesion genes were also investigated at
pH 4.0. Variations in pH did not influence the expression of
the genes negatively, as none were down-regulated at lower
pH.
Regulation of MapA was also investigated. Expression of
MapA from L. reuteri 104R is regulated by a mechanism of
transcription attenuation, involving cysteine (information
published in Genebank, accession number AJ 293860). Our
studies indicate that the MapA gene of L. plantarum 423 is
down-regulated in the presence of 0.1% (w/v) l-cysteine HCl.
Cysteine participates as an effector molecule and represses
transcription of MapA in the presence of cysteine.
5. Conclusion
L. plantarum 423 complies with all the major criteria re-
quired to be classified as a probiotic. Expression of plaA was
not affected by digestive stress conditions in vitro and strain 423
survived exposure to HCl at pH 2.0. Expression of adhesion
genes by strain 423 was positively regulated in the presence of
mucus. Variations in pH did not affect expression of the ad-
hesion genes, whilst bile and pancreatin only affected the Mub
gene. L. plantarum 423 is capable of adapting to conditions in a
normal healthy intestine and has the genetic characteristics
required for an effective probiotic.
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